<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cf3d3-64f4-7c23-af0e-9233138fcc51,g:0228344d-9d05-4543-acc1-8f0499414550-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://telixpharma.com/role/Cover" xlink:type="simple" xlink:href="tlx-20260630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019fea1a-3f29-76bc-9c8e-49c8efe7c702" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_DocumentType_019fea1a-3f29-76bc-9c8e-49c8efe7c702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019fea1a-3f29-72e6-b5d6-b23dbe3b51ae" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityFileNumber_019fea1a-3f29-72e6-b5d6-b23dbe3b51ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019fea1a-3f29-7729-b48a-dfef052bd4e5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityRegistrantName_019fea1a-3f29-7729-b48a-dfef052bd4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019fea1a-3f29-7b0e-b31f-97c08253499f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityAddressAddressLine1_019fea1a-3f29-7b0e-b31f-97c08253499f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019fea1a-3f29-73e3-9083-8499e9562ee0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityAddressCityOrTown_019fea1a-3f29-73e3-9083-8499e9562ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019fea1a-3f29-7244-8efe-ca37621f9b18" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityAddressStateOrProvince_019fea1a-3f29-7244-8efe-ca37621f9b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019fea1a-3f29-77f3-9b7d-785ffc591f03" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityAddressPostalZipCode_019fea1a-3f29-77f3-9b7d-785ffc591f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_019fea1a-3f29-7e26-9089-776160bf9446" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityAddressCountry_019fea1a-3f29-7e26-9089-776160bf9446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019fea1c-eb37-72ad-bf05-ff9e1466dc09" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_AmendmentFlag_019fea1c-eb37-72ad-bf05-ff9e1466dc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019fea1c-eb37-79f4-be9b-1f3bc55ec16f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_DocumentPeriodEndDate_019fea1c-eb37-79f4-be9b-1f3bc55ec16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019fea1c-eb37-7d4a-bc74-58bad9a0b731" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_EntityCentralIndexKey_019fea1c-eb37-7d4a-bc74-58bad9a0b731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019fea1c-eb37-75f4-89f2-16a2b7945bb5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cf3d3-6a28-77cb-87b7-f4ba86353c6d" xlink:to="loc_dei_CurrentFiscalYearEndDate_019fea1c-eb37-75f4-89f2-16a2b7945bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Interimconsolidatedstatementofcomprehensiveincome" xlink:type="simple" xlink:href="tlx-20260630.xsd#Interimconsolidatedstatementofcomprehensiveincome"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Interimconsolidatedstatementofcomprehensiveincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeStatementAbstract_019cf3d3-6a28-7337-9fda-119b0e5550df" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:href="tlx-20260630.xsd#tlx_ComprehensiveIncomeFromContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019cf3d3-6a28-7337-9fda-119b0e5550df" xlink:to="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019cf3d3-6a28-7bf6-9e18-071246870625" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019cf3d3-6a28-7bf6-9e18-071246870625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_019cf3d3-6a28-746f-a3f9-92ba5b44fd9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_CostOfSales_019cf3d3-6a28-746f-a3f9-92ba5b44fd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_019cf3d3-6a28-7aed-8b6f-9132be239e2a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_GrossProfit_019cf3d3-6a28-7aed-8b6f-9132be239e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_019fad37-c168-74fe-b8fe-c13a15f64a72" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_OtherIncome_019fad37-c168-74fe-b8fe-c13a15f64a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_019cf3d3-6a28-7c6c-85d8-91bab24deded" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_019cf3d3-6a28-7c6c-85d8-91bab24deded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_019cf3d3-6a28-7d82-9e38-8bb7837bc2db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_019cf3d3-6a28-7d82-9e38-8bb7837bc2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ManufacturingAndDistributionCosts_019cf3d3-6a28-7321-b3c0-c3c57086722b" xlink:href="tlx-20260630.xsd#tlx_ManufacturingAndDistributionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_tlx_ManufacturingAndDistributionCosts_019cf3d3-6a28-7321-b3c0-c3c57086722b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_019cf3d3-6a28-7ac9-910e-6b1b26e44344" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_019cf3d3-6a28-7ac9-910e-6b1b26e44344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherGainsLosses_019cf3d3-6a28-7e92-a6ec-4f200f249d0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_OtherGainsLosses_019cf3d3-6a28-7e92-a6ec-4f200f249d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_019cf3d3-6a28-7431-8db1-dfaa8648f62d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_019cf3d3-6a28-7431-8db1-dfaa8648f62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_019cf3d3-6a28-78d0-bba2-c714ee573230" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_FinanceIncome_019cf3d3-6a28-78d0-bba2-c714ee573230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_019cf3d3-6a28-7464-9efc-38423f2591d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_FinanceCosts_019cf3d3-6a28-7464-9efc-38423f2591d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_019cf3d3-6a28-7a53-b153-d15757eb2b6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_019cf3d3-6a28-7a53-b153-d15757eb2b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019cf3d3-6a28-7c36-b5a0-edb16f5cb95f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019cf3d3-6a28-7c36-b5a0-edb16f5cb95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019cf3d3-6a28-78c9-af91-f6b56926db6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_ProfitLoss_019cf3d3-6a28-78c9-af91-f6b56926db6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToAbstract_019cf3d3-6a28-71fc-8ef0-a04c9f9f6054" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_ProfitLossAttributableToAbstract_019cf3d3-6a28-71fc-8ef0-a04c9f9f6054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019cf3d3-6a28-75c0-9c9c-107b0c5758cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_019cf3d3-6a28-71fc-8ef0-a04c9f9f6054" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019cf3d3-6a28-75c0-9c9c-107b0c5758cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019cf3d3-6a28-7e35-8321-8563a54cd590" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019cf3d3-6a28-7e35-8321-8563a54cd590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019cf3d3-6a28-75bc-843a-5fc05e654334" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019cf3d3-6a28-7e35-8321-8563a54cd590" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019cf3d3-6a28-75bc-843a-5fc05e654334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_019cf3d3-6a28-7265-824f-f5cdece3cfd5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019cf3d3-6a28-75bc-843a-5fc05e654334" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_019cf3d3-6a28-7265-824f-f5cdece3cfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019cf3d3-6a28-7206-b5ef-d5589e3525f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019cf3d3-6a28-7e35-8321-8563a54cd590" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019cf3d3-6a28-7206-b5ef-d5589e3525f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_019cf3d3-6a28-7087-b9b6-50e44206a8f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019cf3d3-6a28-7206-b5ef-d5589e3525f2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_019cf3d3-6a28-7087-b9b6-50e44206a8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019cf3d3-6a28-7b8d-9386-e0008f3c7b0c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019cf3d3-6a28-7e35-8321-8563a54cd590" xlink:to="loc_ifrs-full_ComprehensiveIncome_019cf3d3-6a28-7b8d-9386-e0008f3c7b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_019cf3d3-6a28-7836-afef-8c2a430616fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_019cf3d3-6a28-7836-afef-8c2a430616fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_019cf3d3-6a28-7129-8d19-396d1c5ab670" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_019cf3d3-6a28-7836-afef-8c2a430616fe" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_019cf3d3-6a28-7129-8d19-396d1c5ab670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_019cf3d3-6a28-7a2e-bea2-c8a18a3c0ea6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ComprehensiveIncomeFromContinuingOperationsAbstract_019cf3d3-6a28-7674-a98c-bcce58fb069f" xlink:to="loc_ifrs-full_EarningsPerShareAbstract_019cf3d3-6a28-7a2e-bea2-c8a18a3c0ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_019cf3d3-6a28-7b07-8301-a30c6200493b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019cf3d3-6a28-7a2e-bea2-c8a18a3c0ea6" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_019cf3d3-6a28-7b07-8301-a30c6200493b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_019cf3d3-6a28-791f-9ad3-6a1e967222dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019cf3d3-6a28-7a2e-bea2-c8a18a3c0ea6" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_019cf3d3-6a28-791f-9ad3-6a1e967222dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Interimconsolidatedstatementoffinancialposition" xlink:type="simple" xlink:href="tlx-20260630.xsd#Interimconsolidatedstatementoffinancialposition"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Interimconsolidatedstatementoffinancialposition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6a28-7e2c-9376-ae6bbfa4dba4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6a28-7e2c-9376-ae6bbfa4dba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_019cf3d3-6a28-73ae-99b5-6cb14f71a2a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_019cf3d3-6a28-73ae-99b5-6cb14f71a2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_019cf3d3-6a28-7e82-93ff-e3e57a1ce8fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:to="loc_ifrs-full_Inventories_019cf3d3-6a28-7e82-93ff-e3e57a1ce8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent_019cf3d3-6a28-7561-baaa-b1f371ca59f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:to="loc_ifrs-full_CurrentTaxAssetsCurrent_019cf3d3-6a28-7561-baaa-b1f371ca59f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentAssets_019cf3d3-6a28-711c-afe5-0c2b25cf97d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:to="loc_ifrs-full_OtherCurrentAssets_019cf3d3-6a28-711c-afe5-0c2b25cf97d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_019cf3d3-6a28-7e8a-9485-f85a41a01f82" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019cf3d3-6a28-7321-b2a6-e25a77dbbf86" xlink:to="loc_ifrs-full_CurrentAssets_019cf3d3-6a28-7e8a-9485-f85a41a01f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_019cf3d3-6a28-7e0d-9f4f-65e0f344e25b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_019cf3d3-6a28-7e0d-9f4f-65e0f344e25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_019cf3d3-6a28-71b9-a127-9ca69cdb6946" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:to="loc_ifrs-full_DeferredTaxAssets_019cf3d3-6a28-71b9-a127-9ca69cdb6946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019cf3d3-6a28-7964-926b-092b07b0b117" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_019cf3d3-6a28-7964-926b-092b07b0b117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_019cf3d3-6a28-7a3a-8fcf-19172a35f263" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:to="loc_ifrs-full_RightofuseAssets_019cf3d3-6a28-7a3a-8fcf-19172a35f263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_019cf3d3-6a28-79dd-8ea4-a3ed0448836f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_019cf3d3-6a28-79dd-8ea4-a3ed0448836f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_019cf3d3-6a28-711f-8ad8-578aa0c26544" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_019cf3d3-6a28-711f-8ad8-578aa0c26544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_019cf3d3-6a28-7775-bd56-6771774b3c7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019cf3d3-6a28-7ff3-a3cd-ee1f3964ca47" xlink:to="loc_ifrs-full_NoncurrentAssets_019cf3d3-6a28-7775-bd56-6771774b3c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_019cf3d3-6a28-7f14-94da-d557241fafb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_Assets_019cf3d3-6a28-7f14-94da-d557241fafb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_019cf3d3-6a28-7197-b45e-ecd87cb3da76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_019cf3d3-6a28-7197-b45e-ecd87cb3da76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowings_019cf3d3-6a28-7924-bc9b-4beaa84a914a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_ifrs-full_ShorttermBorrowings_019cf3d3-6a28-7924-bc9b-4beaa84a914a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_019cf3d3-6a28-7ba6-b571-9d5c1e085610" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_019cf3d3-6a28-7ba6-b571-9d5c1e085610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_019cf3d3-6a28-733b-9c02-46c86b9ad5cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_ifrs-full_CurrentContractLiabilities_019cf3d3-6a28-733b-9c02-46c86b9ad5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_019cf3d3-6a28-7c12-9faf-9c1895e3040c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_019cf3d3-6a28-7c12-9faf-9c1895e3040c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentProvisions_019cf3d3-6a28-716d-9c71-3df416dcbbe5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_ifrs-full_CurrentProvisions_019cf3d3-6a28-716d-9c71-3df416dcbbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_CurrentContingentConsideration_019cf3d3-6a28-7936-9fd8-99950d240ae2" xlink:href="tlx-20260630.xsd#tlx_CurrentContingentConsideration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_tlx_CurrentContingentConsideration_019cf3d3-6a28-7936-9fd8-99950d240ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_CurrentEmployeeBenefitObligations_019cf3d3-6a28-73ec-8199-9c26890be852" xlink:href="tlx-20260630.xsd#tlx_CurrentEmployeeBenefitObligations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_tlx_CurrentEmployeeBenefitObligations_019cf3d3-6a28-73ec-8199-9c26890be852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_019cf3d3-6a28-7de6-a0f3-253176191eef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019cf3d3-6a28-709b-b2f0-74192a5c7b04" xlink:to="loc_ifrs-full_CurrentLiabilities_019cf3d3-6a28-7de6-a0f3-253176191eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_019cf3d3-6a28-7830-b8b8-2c7f98c226df" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_ifrs-full_LongtermBorrowings_019cf3d3-6a28-7830-b8b8-2c7f98c226df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_019cf3d3-6a28-70c9-9bac-87180e1178fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_019cf3d3-6a28-70c9-9bac-87180e1178fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_019cf3d3-6a28-72ac-9cc3-1a730914a9ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_019cf3d3-6a28-72ac-9cc3-1a730914a9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_019cf3d3-6adf-7fe2-a57e-6861de83882c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_019cf3d3-6adf-7fe2-a57e-6861de83882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_019cf3d3-6adf-71ba-b4ef-4c7ac018934b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_ifrs-full_NoncurrentProvisions_019cf3d3-6adf-71ba-b4ef-4c7ac018934b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_NonCurrentContingentConsideration_019cf3d3-6adf-7d2c-8e99-f3af782b3e6b" xlink:href="tlx-20260630.xsd#tlx_NonCurrentContingentConsideration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_tlx_NonCurrentContingentConsideration_019cf3d3-6adf-7d2c-8e99-f3af782b3e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_NonCurrentEmployeeBenefitObligations_019cf3d3-6adf-71ca-9840-33b04a9deb85" xlink:href="tlx-20260630.xsd#tlx_NonCurrentEmployeeBenefitObligations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_tlx_NonCurrentEmployeeBenefitObligations_019cf3d3-6adf-71ca-9840-33b04a9deb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_019cf3d3-6adf-79cd-ad42-9f0e4ec35bf1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019cf3d3-6a28-7d2a-a342-c3338e13b2d7" xlink:to="loc_ifrs-full_NoncurrentLiabilities_019cf3d3-6adf-79cd-ad42-9f0e4ec35bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_019cf3d3-6adf-7f3c-936e-835b2b803856" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_Liabilities_019cf3d3-6adf-7f3c-936e-835b2b803856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetAssetsLiabilities_019cf3d3-6adf-709b-998c-e879473d1f7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_NetAssetsLiabilities_019cf3d3-6adf-709b-998c-e879473d1f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_019cf3d3-6adf-7662-9d67-fc4b34bed13e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019cf3d3-6a28-7606-b2f1-0dd756ae4132" xlink:to="loc_ifrs-full_EquityAbstract_019cf3d3-6adf-7662-9d67-fc4b34bed13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_019cf3d3-6adf-7365-ae83-6b4cd56bd6e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6adf-7662-9d67-fc4b34bed13e" xlink:to="loc_ifrs-full_IssuedCapital_019cf3d3-6adf-7365-ae83-6b4cd56bd6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_CapitalReserveDeficit_019cf3d3-6adf-7c68-b869-72bfd7a11cf7" xlink:href="tlx-20260630.xsd#tlx_CapitalReserveDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6adf-7662-9d67-fc4b34bed13e" xlink:to="loc_tlx_CapitalReserveDeficit_019cf3d3-6adf-7c68-b869-72bfd7a11cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_019cf3d3-6adf-7391-9e86-7cdbfeb687ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6adf-7662-9d67-fc4b34bed13e" xlink:to="loc_ifrs-full_OtherReserves_019cf3d3-6adf-7391-9e86-7cdbfeb687ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings_019cf3d3-6adf-74af-9b8e-126b5871c1a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6adf-7662-9d67-fc4b34bed13e" xlink:to="loc_ifrs-full_RetainedEarnings_019cf3d3-6adf-74af-9b8e-126b5871c1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019cf3d3-6adf-755d-881e-8364d3945595" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6adf-7662-9d67-fc4b34bed13e" xlink:to="loc_ifrs-full_Equity_019cf3d3-6adf-755d-881e-8364d3945595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Interimconsolidatedstatementofchangesinequity" xlink:type="simple" xlink:href="tlx-20260630.xsd#Interimconsolidatedstatementofchangesinequity"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Interimconsolidatedstatementofchangesinequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_019cf3d3-6adf-7895-9c86-e7e25373aa43" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_019cf3d3-6adf-7e3c-ac4a-b7cc8f497739" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_019cf3d3-6adf-7895-9c86-e7e25373aa43" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_019cf3d3-6adf-7e3c-ac4a-b7cc8f497739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6adf-761f-b807-2c025309af5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_019cf3d3-6adf-7e3c-ac4a-b7cc8f497739" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6adf-761f-b807-2c025309af5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6adf-7faa-bed5-b52b08ce33e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6adf-761f-b807-2c025309af5e" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6adf-7faa-bed5-b52b08ce33e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019cf3d3-6adf-740a-8e73-6c1c511a1373" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6adf-7faa-bed5-b52b08ce33e7" xlink:to="loc_ifrs-full_IssuedCapitalMember_019cf3d3-6adf-740a-8e73-6c1c511a1373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalReserveMember_019cf3d3-6adf-70aa-8146-a45dc10d8233" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserveMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6adf-7faa-bed5-b52b08ce33e7" xlink:to="loc_ifrs-full_CapitalReserveMember_019cf3d3-6adf-70aa-8146-a45dc10d8233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_019cf3d3-6adf-7fe4-bc51-be4116504331" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6adf-7faa-bed5-b52b08ce33e7" xlink:to="loc_ifrs-full_OtherReservesMember_019cf3d3-6adf-7fe4-bc51-be4116504331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_019cf3d3-6adf-7e7f-8f94-98d9a0828088" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6adf-7faa-bed5-b52b08ce33e7" xlink:to="loc_ifrs-full_RetainedEarningsMember_019cf3d3-6adf-7e7f-8f94-98d9a0828088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_019cf3d3-6adf-78a1-981a-fcf6282e97ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_019cf3d3-6adf-7e3c-ac4a-b7cc8f497739" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_019cf3d3-6adf-78a1-981a-fcf6282e97ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019cf3d3-6adf-78a1-981a-fcf6282e97ad" xlink:to="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019cf3d3-6adf-741c-a438-705563c4ee05" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_Equity_019cf3d3-6adf-741c-a438-705563c4ee05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019cf3d3-6adf-7522-8cea-a03fb3bb52a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_ProfitLoss_019cf3d3-6adf-7522-8cea-a03fb3bb52a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_019cf3d3-6adf-759a-b6db-e6aa2ab34f71" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_019cf3d3-6adf-759a-b6db-e6aa2ab34f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019cf3d3-6adf-7114-b94f-300a2c453319" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_ComprehensiveIncome_019cf3d3-6adf-7114-b94f-300a2c453319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019cf3d3-6adf-7429-a485-803ac79f372c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_IssueOfEquity_019cf3d3-6adf-7429-a485-803ac79f372c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_019cf3d3-6adf-7fec-94ee-bda0f5b30da7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_019cf3d3-6adf-7fec-94ee-bda0f5b30da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_RepurchaseOfConvertibleBonds_019ed044-8e2e-70ed-84ca-f673104df4a8" xlink:href="tlx-20260630.xsd#tlx_RepurchaseOfConvertibleBonds"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_tlx_RepurchaseOfConvertibleBonds_019ed044-8e2e-70ed-84ca-f673104df4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_019cf3d3-6adf-71c1-a736-bfd0632bde1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_IssueOfConvertibleInstruments_019cf3d3-6adf-71c1-a736-bfd0632bde1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughTransactionCostsArisingOnConvertibleBondsIssue_019cf3d3-6adf-7f97-bceb-a11d36d142d7" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughTransactionCostsArisingOnConvertibleBondsIssue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_tlx_IncreaseDecreaseThroughTransactionCostsArisingOnConvertibleBondsIssue_019cf3d3-6adf-7f97-bceb-a11d36d142d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019cf3d3-6adf-7689-812a-110c3c887e73" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019cf3d3-6adf-7689-812a-110c3c887e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughShareBasedPaymentTransactionsAssociatedWithAcquisitionsEquity_019cf3d3-6adf-71a8-a599-2cd802a5d154" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughShareBasedPaymentTransactionsAssociatedWithAcquisitionsEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_tlx_IncreaseDecreaseThroughShareBasedPaymentTransactionsAssociatedWithAcquisitionsEquity_019cf3d3-6adf-71a8-a599-2cd802a5d154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughTransferOnSatisfactionOfAcquisitionPerformanceRights_019cf3d3-6adf-71f5-95c4-9ef202c7a6b3" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughTransferOnSatisfactionOfAcquisitionPerformanceRights"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_tlx_IncreaseDecreaseThroughTransferOnSatisfactionOfAcquisitionPerformanceRights_019cf3d3-6adf-71f5-95c4-9ef202c7a6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughTransferOnExerciseOfOptionsEquity_019cf3d3-6adf-7a91-b18c-58691c0f015d" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughTransferOnExerciseOfOptionsEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_tlx_IncreaseDecreaseThroughTransferOnExerciseOfOptionsEquity_019cf3d3-6adf-7a91-b18c-58691c0f015d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInEquity_019cf3d3-6adf-725e-8db5-2797f5c6df3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_ChangesInEquity_019cf3d3-6adf-725e-8db5-2797f5c6df3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019cf3d3-6adf-713a-abaa-2220d647700e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_019cf3d3-6adf-72f2-9ae8-5dc6b7ef015e" xlink:to="loc_ifrs-full_Equity_019cf3d3-6adf-713a-abaa-2220d647700e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Interimconsolidatedstatementofcashflows" xlink:type="simple" xlink:href="tlx-20260630.xsd#Interimconsolidatedstatementofcashflows"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Interimconsolidatedstatementofcashflows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceiptsFromSalesOfGoodsAndRenderingOfServices_019cf3d3-6adf-7fab-9159-88eef8c941c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceiptsFromSalesOfGoodsAndRenderingOfServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_ifrs-full_ReceiptsFromSalesOfGoodsAndRenderingOfServices_019cf3d3-6adf-7fab-9159-88eef8c941c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ReceiptsFromCollaborationAgreements_019ed04b-1b92-7123-85a5-52ac053b01cb" xlink:href="tlx-20260630.xsd#tlx_ReceiptsFromCollaborationAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_tlx_ReceiptsFromCollaborationAgreements_019ed04b-1b92-7123-85a5-52ac053b01cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServicesAndToAndOnBehalfOfEmployees_019cf3d3-6adf-7e92-b62d-6e4cf0085aff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServicesAndToAndOnBehalfOfEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServicesAndToAndOnBehalfOfEmployees_019cf3d3-6adf-7e92-b62d-6e4cf0085aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_PaymentsForContingentConsiderationClassifiedAsOperatingActivities_019cf3d3-6adf-7805-bce9-78135dff4914" xlink:href="tlx-20260630.xsd#tlx_PaymentsForContingentConsiderationClassifiedAsOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_tlx_PaymentsForContingentConsiderationClassifiedAsOperatingActivities_019cf3d3-6adf-7805-bce9-78135dff4914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_019cf3d3-6adf-7baf-8ef8-2d3f00ab03d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_019cf3d3-6adf-7baf-8ef8-2d3f00ab03d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_019cf3d3-6adf-7c81-bedd-a43ff48bbc53" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_019cf3d3-6adf-7c81-bedd-a43ff48bbc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_019cf3d3-6adf-764c-9078-1307c52ac8eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_019cf3d3-6adf-764c-9078-1307c52ac8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019cf3d3-6adf-7df8-95c3-e503c6e45dc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019cf3d3-6adf-7873-9f9b-8d2b12496034" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019cf3d3-6adf-7df8-95c3-e503c6e45dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_019cf3d3-6adf-7f09-bc73-5585f224c6f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_019cf3d3-6adf-7f09-bc73-5585f224c6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_019cf3d3-6adf-78ac-8d41-1fedff44315f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_019cf3d3-6adf-78ac-8d41-1fedff44315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_019cf3d3-6adf-707d-b5f5-1b6ce9f5cf4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_019cf3d3-6adf-707d-b5f5-1b6ce9f5cf4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_019cf3d3-6adf-7c7f-918f-2484823d45dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_019cf3d3-6adf-7c7f-918f-2484823d45dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019cf3d3-6adf-77a8-83d9-af4f70c07779" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019cf3d3-6adf-77a8-83d9-af4f70c07779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_PurchaseOfContingentConsiderationClassifiedAsInvestingActivities_019cf3d3-6adf-77ed-bb8d-771f670df07b" xlink:href="tlx-20260630.xsd#tlx_PurchaseOfContingentConsiderationClassifiedAsInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_tlx_PurchaseOfContingentConsiderationClassifiedAsInvestingActivities_019cf3d3-6adf-77ed-bb8d-771f670df07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_PaymentsOfDeferredConsiderationClassifiedAsInvestingActivities_019cf3d3-6adf-7ab7-9976-8b371af6b938" xlink:href="tlx-20260630.xsd#tlx_PaymentsOfDeferredConsiderationClassifiedAsInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_tlx_PaymentsOfDeferredConsiderationClassifiedAsInvestingActivities_019cf3d3-6adf-7ab7-9976-8b371af6b938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019cf3d3-6adf-7308-acc0-e608250536a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019cf3d3-6adf-74e8-8e3a-6c34a4f0341e" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019cf3d3-6adf-7308-acc0-e608250536a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019cf3d3-6adf-7f39-86dc-b0d879c491fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019cf3d3-6adf-7f39-86dc-b0d879c491fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_019cf3d3-6adf-7d2a-b00e-92045316a002" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019cf3d3-6adf-7f39-86dc-b0d879c491fa" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_019cf3d3-6adf-7d2a-b00e-92045316a002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_019cf3d3-6adf-7533-832b-6f82fed664b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019cf3d3-6adf-7f39-86dc-b0d879c491fa" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_019cf3d3-6adf-7533-832b-6f82fed664b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_019cf3d3-6adf-7329-af81-313fc80948e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019cf3d3-6adf-7f39-86dc-b0d879c491fa" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_019cf3d3-6adf-7329-af81-313fc80948e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_019cf3d3-6adf-774e-aba9-49ab263b4f61" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019cf3d3-6adf-7f39-86dc-b0d879c491fa" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_019cf3d3-6adf-774e-aba9-49ab263b4f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019cf3d3-6adf-7675-94e8-eacef0805d73" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019cf3d3-6adf-7f39-86dc-b0d879c491fa" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019cf3d3-6adf-7675-94e8-eacef0805d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019cf3d3-6adf-791d-95b0-2e8b8a2cc6ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019cf3d3-6adf-791d-95b0-2e8b8a2cc6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_019cf3d3-6adf-776b-b1ed-876b8a8e0b1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_019cf3d3-6adf-776b-b1ed-876b8a8e0b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6adf-72ab-9eb1-c53423e5ceab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6adf-72ab-9eb1-c53423e5ceab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6adf-7951-91c4-6dc2b5de5847" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019cf3d3-6adf-776d-8649-82986bd2806a" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6adf-7951-91c4-6dc2b5de5847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Corporateinformation" xlink:type="simple" xlink:href="tlx-20260630.xsd#Corporateinformation"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Corporateinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_CorporateInformationAbstract_019cf3d3-6adf-73d4-a934-f600a18627be" xlink:href="tlx-20260630.xsd#tlx_CorporateInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_019cf3d3-6adf-7569-94a5-d5fce3ccff5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_CorporateInformationAbstract_019cf3d3-6adf-73d4-a934-f600a18627be" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_019cf3d3-6adf-7569-94a5-d5fce3ccff5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Materialaccountingpolicyinformation" xlink:type="simple" xlink:href="tlx-20260630.xsd#Materialaccountingpolicyinformation"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Materialaccountingpolicyinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7a7a-b075-8fd4a907a608" xlink:href="tlx-20260630.xsd#tlx_MaterialAccountingPolicyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_019cf3d3-6adf-7998-9eee-fff9d31a6996" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7a7a-b075-8fd4a907a608" xlink:to="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_019cf3d3-6adf-7998-9eee-fff9d31a6996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Segmentreporting" xlink:type="simple" xlink:href="tlx-20260630.xsd#Segmentreporting"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Segmentreporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7c25-b91b-561def9825c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_019cf3d3-6adf-7dc9-9731-87a77f266f7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7c25-b91b-561def9825c2" xlink:to="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_019cf3d3-6adf-7dc9-9731-87a77f266f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Profitandlossinformation" xlink:type="simple" xlink:href="tlx-20260630.xsd#Profitandlossinformation"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Profitandlossinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-7f02-a48f-ba1ecbcdc4a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfProfitAndLossInformationTextBlock_019f1bb2-5fc8-7acb-a9d8-4b52da737d9b" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfProfitAndLossInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-7f02-a48f-ba1ecbcdc4a3" xlink:to="loc_tlx_DisclosureOfProfitAndLossInformationTextBlock_019f1bb2-5fc8-7acb-a9d8-4b52da737d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Intangibleassets" xlink:type="simple" xlink:href="tlx-20260630.xsd#Intangibleassets"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Intangibleassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019cf3d3-6adf-73fe-ae1d-38041fa2d026" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_019cf3d3-6adf-7375-85ca-12bc68c0643f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019cf3d3-6adf-73fe-ae1d-38041fa2d026" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_019cf3d3-6adf-7375-85ca-12bc68c0643f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Borrowings" xlink:type="simple" xlink:href="tlx-20260630.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7af1-87f8-f35523aeebbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_019cf3d3-6bac-759c-b4c8-ddff861d163c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7af1-87f8-f35523aeebbd" xlink:to="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_019cf3d3-6bac-759c-b4c8-ddff861d163c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Contractualmaturitiesoffinancialliabilities" xlink:type="simple" xlink:href="tlx-20260630.xsd#Contractualmaturitiesoffinancialliabilities"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Contractualmaturitiesoffinancialliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract_019ed0f7-e2b8-7d6f-9ef3-9f337c7add8b" xlink:href="tlx-20260630.xsd#tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_019ed0ff-86f2-7d5a-a69a-9d1bfa229709" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract_019ed0f7-e2b8-7d6f-9ef3-9f337c7add8b" xlink:to="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_019ed0ff-86f2-7d5a-a69a-9d1bfa229709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Equity" xlink:type="simple" xlink:href="tlx-20260630.xsd#Equity"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-7880-86b7-7a83f84c2185" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_019cf3d3-6bad-7068-b3b9-9421d04570f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-7880-86b7-7a83f84c2185" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_019cf3d3-6bad-7068-b3b9-9421d04570f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Fairvalue" xlink:type="simple" xlink:href="tlx-20260630.xsd#Fairvalue"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Fairvalue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_FairValueAbstract_019fc73d-4d54-7dd3-a23d-963f432b316b" xlink:href="tlx-20260630.xsd#tlx_FairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementExplanatory_019fc742-f204-7c98-8e02-95126b2c40e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_FairValueAbstract_019fc73d-4d54-7dd3-a23d-963f432b316b" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementExplanatory_019fc742-f204-7c98-8e02-95126b2c40e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ContingentliabilitiesandCommitments" xlink:type="simple" xlink:href="tlx-20260630.xsd#ContingentliabilitiesandCommitments"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ContingentliabilitiesandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_019cf3d3-6c81-714b-929f-59df33007a83" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_019cf3d3-6c81-74a6-acf2-27b8806c9c93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_019cf3d3-6c81-714b-929f-59df33007a83" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_019cf3d3-6c81-74a6-acf2-27b8806c9c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/Eventsoccurringafterthereportingperiod" xlink:type="simple" xlink:href="tlx-20260630.xsd#Eventsoccurringafterthereportingperiod"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/Eventsoccurringafterthereportingperiod" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_019cf3d3-6c81-73d5-bbf8-ff9fa2e0ebdb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_019cf3d3-6c81-70f0-9daa-1e4b788cdb06" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_019cf3d3-6c81-73d5-bbf8-ff9fa2e0ebdb" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_019cf3d3-6c81-70f0-9daa-1e4b788cdb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/MaterialaccountingpolicyinformationPolicies" xlink:type="simple" xlink:href="tlx-20260630.xsd#MaterialaccountingpolicyinformationPolicies"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/MaterialaccountingpolicyinformationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7635-926c-dd99e7033d88" xlink:href="tlx-20260630.xsd#tlx_MaterialAccountingPolicyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_01a016b2-d37b-7adc-9bfb-11133f20ce01" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7635-926c-dd99e7033d88" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_01a016b2-d37b-7adc-9bfb-11133f20ce01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_019cf3d3-6adf-70ff-88f1-4dfc2768b1fd" xlink:href="tlx-20260630.xsd#tlx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7635-926c-dd99e7033d88" xlink:to="loc_tlx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_019cf3d3-6adf-70ff-88f1-4dfc2768b1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock_019f0366-a2a4-77f4-ba0b-ea40de4d9570" xlink:href="tlx-20260630.xsd#tlx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7635-926c-dd99e7033d88" xlink:to="loc_tlx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock_019f0366-a2a4-77f4-ba0b-ea40de4d9570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/SegmentreportingTables" xlink:type="simple" xlink:href="tlx-20260630.xsd#SegmentreportingTables"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/SegmentreportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7f62-94bd-b1a7e0a6e094" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_019cf3d3-6adf-7f51-8695-96b62e47e38b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7f62-94bd-b1a7e0a6e094" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_019cf3d3-6adf-7f51-8695-96b62e47e38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_019cf3d3-6adf-7b70-8a30-1870fd18d09f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7f62-94bd-b1a7e0a6e094" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_019cf3d3-6adf-7b70-8a30-1870fd18d09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ProfitandlossinformationTables" xlink:type="simple" xlink:href="tlx-20260630.xsd#ProfitandlossinformationTables"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ProfitandlossinformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-78d8-bf0c-c82d529d3e1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_019cf3d3-6adf-7e42-a688-fd84ed5b2217" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-78d8-bf0c-c82d529d3e1e" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_019cf3d3-6adf-7e42-a688-fd84ed5b2217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfDetailedInformationAboutEmploymentCostsTextBlock_019ed077-e355-75c4-8c72-2370888bd234" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfDetailedInformationAboutEmploymentCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-78d8-bf0c-c82d529d3e1e" xlink:to="loc_tlx_DisclosureOfDetailedInformationAboutEmploymentCostsTextBlock_019ed077-e355-75c4-8c72-2370888bd234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ScheduleOfDisclosureOfDepreciationAndAmortizationTextBlock_019ed078-4d36-7e07-890c-86f6f7ac8651" xlink:href="tlx-20260630.xsd#tlx_ScheduleOfDisclosureOfDepreciationAndAmortizationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-78d8-bf0c-c82d529d3e1e" xlink:to="loc_tlx_ScheduleOfDisclosureOfDepreciationAndAmortizationTextBlock_019ed078-4d36-7e07-890c-86f6f7ac8651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfOtherIncomeTextBlock_019ed078-b203-7f21-9c1d-0b83fcf67e93" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfOtherIncomeTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-78d8-bf0c-c82d529d3e1e" xlink:to="loc_tlx_DisclosureOfOtherIncomeTextBlock_019ed078-b203-7f21-9c1d-0b83fcf67e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfDetailedInformationAboutFinanceCostsTextBlock_019ed079-146d-791e-8e7c-bee31bc14fe6" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfDetailedInformationAboutFinanceCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-78d8-bf0c-c82d529d3e1e" xlink:to="loc_tlx_DisclosureOfDetailedInformationAboutFinanceCostsTextBlock_019ed079-146d-791e-8e7c-bee31bc14fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/IntangibleassetsTables" xlink:type="simple" xlink:href="tlx-20260630.xsd#IntangibleassetsTables"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/IntangibleassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019cf3d3-6adf-759a-b1e0-601843e13327" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_019cf3d3-6adf-78fb-b060-efd88acc6965" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019cf3d3-6adf-759a-b1e0-601843e13327" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_019cf3d3-6adf-78fb-b060-efd88acc6965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/BorrowingsTables" xlink:type="simple" xlink:href="tlx-20260630.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7a72-911c-c980f48f4f02" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_019cf3d3-6bac-7021-8765-84a9d443473d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7a72-911c-c980f48f4f02" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_019cf3d3-6bac-7021-8765-84a9d443473d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfDetailedInformationAboutConvertibleBondsReportedInStatementOfFinancialPositionTableTextBlock_019cf3d3-6bac-77f7-b7d0-e3e82191809d" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfDetailedInformationAboutConvertibleBondsReportedInStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7a72-911c-c980f48f4f02" xlink:to="loc_tlx_DisclosureOfDetailedInformationAboutConvertibleBondsReportedInStatementOfFinancialPositionTableTextBlock_019cf3d3-6bac-77f7-b7d0-e3e82191809d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_019fb8e3-da78-7268-9944-8a11dc22a38e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7a72-911c-c980f48f4f02" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_019fb8e3-da78-7268-9944-8a11dc22a38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ContractualmaturitiesoffinancialliabilitiesTables" xlink:type="simple" xlink:href="tlx-20260630.xsd#ContractualmaturitiesoffinancialliabilitiesTables"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ContractualmaturitiesoffinancialliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract_019ed0f7-e2b8-78e6-9388-e86faf61bdd8" xlink:href="tlx-20260630.xsd#tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_019ed0ff-1626-7542-ae12-6de60300eb07" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract_019ed0f7-e2b8-78e6-9388-e86faf61bdd8" xlink:to="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_019ed0ff-1626-7542-ae12-6de60300eb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/EquityTables" xlink:type="simple" xlink:href="tlx-20260630.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-78d4-8685-1800fbdf60d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_019cf3d3-6bad-7186-ab1c-0929c93da0c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-78d4-8685-1800fbdf60d2" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_019cf3d3-6bad-7186-ab1c-0929c93da0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_019cf3d3-6bad-79ce-8380-e07bf6ffe9dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-78d4-8685-1800fbdf60d2" xlink:to="loc_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_019cf3d3-6bad-79ce-8380-e07bf6ffe9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ContingentliabilitiesandCommitmentsTables" xlink:type="simple" xlink:href="tlx-20260630.xsd#ContingentliabilitiesandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ContingentliabilitiesandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_019fc80c-f866-7494-8cf0-773cc2c281bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfCommitmentsContractualObligationsExplanatoryTableTextBlock_019fb8a8-ba81-745f-967a-4ba20c257562" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfCommitmentsContractualObligationsExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_019fc80c-f866-7494-8cf0-773cc2c281bc" xlink:to="loc_tlx_DisclosureOfCommitmentsContractualObligationsExplanatoryTableTextBlock_019fb8a8-ba81-745f-967a-4ba20c257562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/MaterialaccountingpolicyinformationDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#MaterialaccountingpolicyinformationDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/MaterialaccountingpolicyinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7f50-b552-83fd79b85481" xlink:href="tlx-20260630.xsd#tlx_MaterialAccountingPolicyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019ed05c-c4d2-7b7e-8481-c495b777df25" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7f50-b552-83fd79b85481" xlink:to="loc_ifrs-full_ProfitLoss_019ed05c-c4d2-7b7e-8481-c495b777df25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019ed05c-c4d2-76b0-bda7-8a199b8b3630" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7f50-b552-83fd79b85481" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019ed05c-c4d2-76b0-bda7-8a199b8b3630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetAssetsLiabilities_019ed05c-c4d2-7d25-a2ec-2860ef9ecc7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7f50-b552-83fd79b85481" xlink:to="loc_ifrs-full_NetAssetsLiabilities_019ed05c-c4d2-7d25-a2ec-2860ef9ecc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019ed05c-c4d2-7fdd-b0b4-96f33f408bb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaterialAccountingPolicyInformationAbstract_019cf3d3-6adf-7f50-b552-83fd79b85481" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019ed05c-c4d2-7fdd-b0b4-96f33f408bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/SegmentreportingScheduleofSegmentPerformanceDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#SegmentreportingScheduleofSegmentPerformanceDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/SegmentreportingScheduleofSegmentPerformanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-72e2-868b-28e662bd8664" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7fcf-8621-6ce6459b4d79" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-72e2-868b-28e662bd8664" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7fcf-8621-6ce6459b4d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-716a-81fd-4d34cbc1c192" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7fcf-8621-6ce6459b4d79" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-716a-81fd-4d34cbc1c192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7334-9fdb-234501fba078" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-716a-81fd-4d34cbc1c192" xlink:to="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7334-9fdb-234501fba078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_019cf3d3-6adf-7216-95bf-0bb475de73ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7334-9fdb-234501fba078" xlink:to="loc_ifrs-full_OperatingSegmentsMember_019cf3d3-6adf-7216-95bf-0bb475de73ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_019cf3d3-6adf-7030-936c-0423f4906c8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7334-9fdb-234501fba078" xlink:to="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_019cf3d3-6adf-7030-936c-0423f4906c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-7833-946e-ac13b2135cc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7fcf-8621-6ce6459b4d79" xlink:to="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-7833-946e-ac13b2135cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7b05-b095-47c77e9f4936" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-7833-946e-ac13b2135cc6" xlink:to="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7b05-b095-47c77e9f4936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_PrecisionMedicineMember_019cf3d3-6adf-7cba-911a-03f99cfb15b1" xlink:href="tlx-20260630.xsd#tlx_PrecisionMedicineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7b05-b095-47c77e9f4936" xlink:to="loc_tlx_PrecisionMedicineMember_019cf3d3-6adf-7cba-911a-03f99cfb15b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_TherapeuticsMember_019cf3d3-6adf-7e4e-85e3-b08e024698cf" xlink:href="tlx-20260630.xsd#tlx_TherapeuticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7b05-b095-47c77e9f4936" xlink:to="loc_tlx_TherapeuticsMember_019cf3d3-6adf-7e4e-85e3-b08e024698cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ManufacturingSolutionsMember_019cf3d3-6adf-7deb-9816-9819608fa6d1" xlink:href="tlx-20260630.xsd#tlx_ManufacturingSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7b05-b095-47c77e9f4936" xlink:to="loc_tlx_ManufacturingSolutionsMember_019cf3d3-6adf-7deb-9816-9819608fa6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7fcf-8621-6ce6459b4d79" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019cf3d3-6adf-7557-ae06-56cbed4c6a6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019cf3d3-6adf-7557-ae06-56cbed4c6a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_InterSegmentRevenue_019cf3d3-6adf-7a14-8a33-2ae38c746b6c" xlink:href="tlx-20260630.xsd#tlx_InterSegmentRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_tlx_InterSegmentRevenue_019cf3d3-6adf-7a14-8a33-2ae38c746b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_019cf3d3-6adf-74ef-89e0-101a65595e61" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_CostOfSales_019cf3d3-6adf-74ef-89e0-101a65595e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_019cf3d3-6adf-73cb-934f-eba607bfb705" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_GrossProfit_019cf3d3-6adf-73cb-934f-eba607bfb705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_019fad39-974d-7491-960b-ee400b4bacc4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_OtherIncome_019fad39-974d-7491-960b-ee400b4bacc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_019cf3d3-6adf-7557-9593-8bfaed1de3f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_019cf3d3-6adf-7557-9593-8bfaed1de3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_019cf3d3-6adf-7018-af98-14da20181f66" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_019cf3d3-6adf-7018-af98-14da20181f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ManufacturingAndDistributionCosts_019cf3d3-6adf-71bd-90fc-d548d2ee514f" xlink:href="tlx-20260630.xsd#tlx_ManufacturingAndDistributionCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_tlx_ManufacturingAndDistributionCosts_019cf3d3-6adf-71bd-90fc-d548d2ee514f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_019cf3d3-6adf-7bd2-b921-55aa1c91a990" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_019cf3d3-6adf-7bd2-b921-55aa1c91a990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherGainsLosses_019cf3d3-6adf-7be6-adff-34c4f93f5158" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_OtherGainsLosses_019cf3d3-6adf-7be6-adff-34c4f93f5158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_019cf3d3-6adf-7da7-9283-4772b255dede" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_019cf3d3-6adf-7da7-9283-4772b255dede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherGainsLosses_019cf3d3-6adf-7276-bf31-b159e5ef97bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_OtherGainsLosses_019cf3d3-6adf-7276-bf31-b159e5ef97bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_019cf3d3-6adf-7e67-99ea-f96e3fdd63de" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_019cf3d3-6adf-7e67-99ea-f96e3fdd63de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_AdjustedEarningsLossBeforeInterestTaxDepreciationAndAmortization_019cf3d3-6adf-73a6-963e-4785ac4c0774" xlink:href="tlx-20260630.xsd#tlx_AdjustedEarningsLossBeforeInterestTaxDepreciationAndAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7400-b406-0698ce78579c" xlink:to="loc_tlx_AdjustedEarningsLossBeforeInterestTaxDepreciationAndAmortization_019cf3d3-6adf-73a6-963e-4785ac4c0774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/SegmentreportingScheduleofReconciliationofSegmentAdjustedEBITDAtoProfitLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#SegmentreportingScheduleofReconciliationofSegmentAdjustedEBITDAtoProfitLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/SegmentreportingScheduleofReconciliationofSegmentAdjustedEBITDAtoProfitLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7da2-849c-76ccbf742446" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-708f-92bd-f955af9cc16e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7da2-849c-76ccbf742446" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-708f-92bd-f955af9cc16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-78f2-8bac-abd78b626a06" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-708f-92bd-f955af9cc16e" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-78f2-8bac-abd78b626a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7799-96a1-37a8a22f3885" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-78f2-8bac-abd78b626a06" xlink:to="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7799-96a1-37a8a22f3885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_019cf3d3-6adf-74fa-82fc-3ff0e9f44b7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnallocatedAmountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7799-96a1-37a8a22f3885" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_019cf3d3-6adf-74fa-82fc-3ff0e9f44b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7835-a4c1-0d047aa0b98c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-708f-92bd-f955af9cc16e" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7835-a4c1-0d047aa0b98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ReconciliationOfTotalSegmentAdjustedEBITDAAndGroupAdjustedEBITAToProfitLossBeforeIncomeTaxAbstract_019cf3d3-6adf-7bf4-abf7-b1900f24ce19" xlink:href="tlx-20260630.xsd#tlx_ReconciliationOfTotalSegmentAdjustedEBITDAAndGroupAdjustedEBITAToProfitLossBeforeIncomeTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7835-a4c1-0d047aa0b98c" xlink:to="loc_tlx_ReconciliationOfTotalSegmentAdjustedEBITDAAndGroupAdjustedEBITAToProfitLossBeforeIncomeTaxAbstract_019cf3d3-6adf-7bf4-abf7-b1900f24ce19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_AdjustedEarningsLossBeforeInterestTaxDepreciationAndAmortization_019cf3d3-6adf-71a0-aff6-1fa19171ad86" xlink:href="tlx-20260630.xsd#tlx_AdjustedEarningsLossBeforeInterestTaxDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ReconciliationOfTotalSegmentAdjustedEBITDAAndGroupAdjustedEBITAToProfitLossBeforeIncomeTaxAbstract_019cf3d3-6adf-7bf4-abf7-b1900f24ce19" xlink:to="loc_tlx_AdjustedEarningsLossBeforeInterestTaxDepreciationAndAmortization_019cf3d3-6adf-71a0-aff6-1fa19171ad86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_UnallocatedIncomeExpensesAndEliminationsAbstract_019cf3d3-6adf-725c-9940-d6ee08746661" xlink:href="tlx-20260630.xsd#tlx_UnallocatedIncomeExpensesAndEliminationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ReconciliationOfTotalSegmentAdjustedEBITDAAndGroupAdjustedEBITAToProfitLossBeforeIncomeTaxAbstract_019cf3d3-6adf-7bf4-abf7-b1900f24ce19" xlink:to="loc_tlx_UnallocatedIncomeExpensesAndEliminationsAbstract_019cf3d3-6adf-725c-9940-d6ee08746661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_019cf3d3-6adf-7784-b89c-e787334f6f5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_UnallocatedIncomeExpensesAndEliminationsAbstract_019cf3d3-6adf-725c-9940-d6ee08746661" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_019cf3d3-6adf-7784-b89c-e787334f6f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherGainsLosses_019cf3d3-6adf-7723-9c13-eba24536ec1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_UnallocatedIncomeExpensesAndEliminationsAbstract_019cf3d3-6adf-725c-9940-d6ee08746661" xlink:to="loc_ifrs-full_OtherGainsLosses_019cf3d3-6adf-7723-9c13-eba24536ec1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_019cf3d3-6adf-78f4-bc66-beba96587152" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_UnallocatedIncomeExpensesAndEliminationsAbstract_019cf3d3-6adf-725c-9940-d6ee08746661" xlink:to="loc_ifrs-full_FinanceIncome_019cf3d3-6adf-78f4-bc66-beba96587152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_019cf3d3-6adf-794f-a560-1e1ac3ea2d83" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_UnallocatedIncomeExpensesAndEliminationsAbstract_019cf3d3-6adf-725c-9940-d6ee08746661" xlink:to="loc_ifrs-full_FinanceCosts_019cf3d3-6adf-794f-a560-1e1ac3ea2d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_019cf3d3-6adf-7fa5-92d1-ef8c26b0270e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_UnallocatedIncomeExpensesAndEliminationsAbstract_019cf3d3-6adf-725c-9940-d6ee08746661" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_019cf3d3-6adf-7fa5-92d1-ef8c26b0270e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_019cf3d3-6adf-7803-ab91-f42de118814a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ReconciliationOfTotalSegmentAdjustedEBITDAAndGroupAdjustedEBITAToProfitLossBeforeIncomeTaxAbstract_019cf3d3-6adf-7bf4-abf7-b1900f24ce19" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_019cf3d3-6adf-7803-ab91-f42de118814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/SegmentreportingNarrativeDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#SegmentreportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/SegmentreportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7385-a2ba-f0021abd200f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7722-a51d-4955523d6ddd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7385-a2ba-f0021abd200f" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7722-a51d-4955523d6ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-7f39-8f6c-0f1c6d511c91" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7722-a51d-4955523d6ddd" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-7f39-8f6c-0f1c6d511c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7fdc-957e-e4c6e312be39" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-7f39-8f6c-0f1c6d511c91" xlink:to="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7fdc-957e-e4c6e312be39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_019cf3d3-6adf-7ab9-93f1-1ffe482df604" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnallocatedAmountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7fdc-957e-e4c6e312be39" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_019cf3d3-6adf-7ab9-93f1-1ffe482df604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_019cf3d3-6adf-7c05-ad74-fadd6c12c43d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7fdc-957e-e4c6e312be39" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_019cf3d3-6adf-7c05-ad74-fadd6c12c43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-758f-91db-4585d525bc65" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7722-a51d-4955523d6ddd" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-758f-91db-4585d525bc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_019cf3d3-6adf-7cb4-83dc-02f38bc4e27e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-758f-91db-4585d525bc65" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_019cf3d3-6adf-7cb4-83dc-02f38bc4e27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6adf-71a1-8de9-cfd21d67ff0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-758f-91db-4585d525bc65" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019cf3d3-6adf-71a1-8de9-cfd21d67ff0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_019cf3d3-6adf-7027-9db9-289f53a29e43" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-758f-91db-4585d525bc65" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_019cf3d3-6adf-7027-9db9-289f53a29e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019cf3d3-6adf-7fd9-a5cc-42edbcb28d1a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-758f-91db-4585d525bc65" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_019cf3d3-6adf-7fd9-a5cc-42edbcb28d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_019cf3d3-6adf-7e7e-81dd-ec4f77c63086" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-758f-91db-4585d525bc65" xlink:to="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_019cf3d3-6adf-7e7e-81dd-ec4f77c63086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/SegmentreportingScheduleofOperatingSegmentAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#SegmentreportingScheduleofOperatingSegmentAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/SegmentreportingScheduleofOperatingSegmentAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7c7b-ab22-5eedde831dc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7e1b-8c04-a3eb53b0d0a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7c7b-ab22-5eedde831dc7" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7e1b-8c04-a3eb53b0d0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-7038-b74e-579351faabe3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7e1b-8c04-a3eb53b0d0a6" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-7038-b74e-579351faabe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7bf7-930b-e2507abbab81" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_019cf3d3-6adf-7038-b74e-579351faabe3" xlink:to="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7bf7-930b-e2507abbab81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_019cf3d3-6adf-73e0-b8ce-1c5a349c3705" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7bf7-930b-e2507abbab81" xlink:to="loc_ifrs-full_OperatingSegmentsMember_019cf3d3-6adf-73e0-b8ce-1c5a349c3705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_019cf3d3-6adf-769d-9c48-683cae6a15e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_019cf3d3-6adf-7bf7-930b-e2507abbab81" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_019cf3d3-6adf-769d-9c48-683cae6a15e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-78b2-b0a1-984a443cce2f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7e1b-8c04-a3eb53b0d0a6" xlink:to="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-78b2-b0a1-984a443cce2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-70d3-a5f9-cae3da924670" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-78b2-b0a1-984a443cce2f" xlink:to="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-70d3-a5f9-cae3da924670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_PrecisionMedicineMember_019cf3d3-6adf-769f-bf60-d53ec8a1a4ad" xlink:href="tlx-20260630.xsd#tlx_PrecisionMedicineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-70d3-a5f9-cae3da924670" xlink:to="loc_tlx_PrecisionMedicineMember_019cf3d3-6adf-769f-bf60-d53ec8a1a4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_TherapeuticsMember_019cf3d3-6adf-72d0-a8a6-d3068f036898" xlink:href="tlx-20260630.xsd#tlx_TherapeuticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-70d3-a5f9-cae3da924670" xlink:to="loc_tlx_TherapeuticsMember_019cf3d3-6adf-72d0-a8a6-d3068f036898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ManufacturingSolutionsMember_019cf3d3-6adf-7950-b01f-79063d2d07d1" xlink:href="tlx-20260630.xsd#tlx_ManufacturingSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-70d3-a5f9-cae3da924670" xlink:to="loc_tlx_ManufacturingSolutionsMember_019cf3d3-6adf-7950-b01f-79063d2d07d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7c80-8763-cf61030061ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7e1b-8c04-a3eb53b0d0a6" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7c80-8763-cf61030061ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_OperatingSegmentAssetsAndLiabilitiesAbstract_019cf3d3-6adf-7b13-a563-a59a193fcb6c" xlink:href="tlx-20260630.xsd#tlx_OperatingSegmentAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-7c80-8763-cf61030061ca" xlink:to="loc_tlx_OperatingSegmentAssetsAndLiabilitiesAbstract_019cf3d3-6adf-7b13-a563-a59a193fcb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_019cf3d3-6adf-72dd-a29f-33133446dc44" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OperatingSegmentAssetsAndLiabilitiesAbstract_019cf3d3-6adf-7b13-a563-a59a193fcb6c" xlink:to="loc_ifrs-full_Assets_019cf3d3-6adf-72dd-a29f-33133446dc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_019cf3d3-6adf-7aaa-87e5-385a710fa35a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OperatingSegmentAssetsAndLiabilitiesAbstract_019cf3d3-6adf-7b13-a563-a59a193fcb6c" xlink:to="loc_ifrs-full_Liabilities_019cf3d3-6adf-7aaa-87e5-385a710fa35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsToNoncurrentAssets_019cf3d3-6adf-766f-ad6b-6a6338f952c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OperatingSegmentAssetsAndLiabilitiesAbstract_019cf3d3-6adf-7b13-a563-a59a193fcb6c" xlink:to="loc_ifrs-full_AdditionsToNoncurrentAssets_019cf3d3-6adf-766f-ad6b-6a6338f952c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/SegmentreportingScheduleofGeographicalInformationDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#SegmentreportingScheduleofGeographicalInformationDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/SegmentreportingScheduleofGeographicalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7221-8b3b-d3f5a71fa5ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7791-88be-304844de5984" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019cf3d3-6adf-7221-8b3b-d3f5a71fa5ad" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7791-88be-304844de5984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019cf3d3-6adf-72b3-a3ad-c8098aef5ef5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7791-88be-304844de5984" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019cf3d3-6adf-72b3-a3ad-c8098aef5ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019cf3d3-6adf-72b3-a3ad-c8098aef5ef5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019cf3d3-6adf-7ba1-ae40-85811f90c9ad" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:to="loc_country_US_019cf3d3-6adf-7ba1-ae40-85811f90c9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignCountriesMember_019cf3d3-6adf-74d2-8b93-34153934bb2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ForeignCountriesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:to="loc_ifrs-full_ForeignCountriesMember_019cf3d3-6adf-74d2-8b93-34153934bb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_019cf3d3-6adf-735a-831b-6f67391a8b56" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:to="loc_country_AU_019cf3d3-6adf-735a-831b-6f67391a8b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BE_019cf3d3-6adf-790e-bb40-92d467b1a476" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_BE"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:to="loc_country_BE_019cf3d3-6adf-790e-bb40-92d467b1a476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_019cf3d3-6adf-7010-8116-8e011662843f" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:to="loc_country_CA_019cf3d3-6adf-7010-8116-8e011662843f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_019cf3d3-6adf-7f8c-8f33-26d59f35a37f" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019cf3d3-6adf-706b-baad-b60db7557bd3" xlink:to="loc_country_GB_019cf3d3-6adf-7f8c-8f33-26d59f35a37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-747d-9bbc-04cfa9a818ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019cf3d3-6adf-7791-88be-304844de5984" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-747d-9bbc-04cfa9a818ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019cf3d3-6adf-7100-b517-462c4b9fcf57" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-747d-9bbc-04cfa9a818ed" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019cf3d3-6adf-7100-b517-462c4b9fcf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_019cf3d3-6adf-7ab8-a971-5097b9fd363b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019cf3d3-6adf-747d-9bbc-04cfa9a818ed" xlink:to="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_019cf3d3-6adf-7ab8-a971-5097b9fd363b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ProfitandlossinformationScheduleofRevenuefromContractswithCustomersDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ProfitandlossinformationScheduleofRevenuefromContractswithCustomersDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ProfitandlossinformationScheduleofRevenuefromContractswithCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-7a17-b134-68cc0068eea8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019cf3d3-6adf-72de-ae31-f38ac2a6d16f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019cf3d3-6adf-7a17-b134-68cc0068eea8" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019cf3d3-6adf-72de-ae31-f38ac2a6d16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_019cf3d3-6adf-738a-bb4f-605268c7f39c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019cf3d3-6adf-72de-ae31-f38ac2a6d16f" xlink:to="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_019cf3d3-6adf-738a-bb4f-605268c7f39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_019cf3d3-6adf-7916-9032-7db22b91cce4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_019cf3d3-6adf-738a-bb4f-605268c7f39c" xlink:to="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_019cf3d3-6adf-7916-9032-7db22b91cce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_019cf3d3-6adf-744a-bfcd-1b92a909ecf0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_019cf3d3-6adf-7916-9032-7db22b91cce4" xlink:to="loc_ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_019cf3d3-6adf-744a-bfcd-1b92a909ecf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodsOrServicesTransferredOverTimeMember_019cf3d3-6adf-7e02-ac57-551afa78a0ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_019cf3d3-6adf-7916-9032-7db22b91cce4" xlink:to="loc_ifrs-full_GoodsOrServicesTransferredOverTimeMember_019cf3d3-6adf-7e02-ac57-551afa78a0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-79f7-86d1-cdccc9261d0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019cf3d3-6adf-72de-ae31-f38ac2a6d16f" xlink:to="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-79f7-86d1-cdccc9261d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7192-98ae-8ef3850da395" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_019cf3d3-6adf-79f7-86d1-cdccc9261d0a" xlink:to="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7192-98ae-8ef3850da395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_PrecisionMedicineMember_019cf3d3-6adf-7832-ac2a-eb2f2ac4d4b1" xlink:href="tlx-20260630.xsd#tlx_PrecisionMedicineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7192-98ae-8ef3850da395" xlink:to="loc_tlx_PrecisionMedicineMember_019cf3d3-6adf-7832-ac2a-eb2f2ac4d4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ManufacturingSolutionsMember_019cf3d3-6adf-75e8-a9c9-fd31747f1d24" xlink:href="tlx-20260630.xsd#tlx_ManufacturingSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7192-98ae-8ef3850da395" xlink:to="loc_tlx_ManufacturingSolutionsMember_019cf3d3-6adf-75e8-a9c9-fd31747f1d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_TherapeuticsMember_019cf3d3-6adf-7eb5-9dbd-f08f22022a9e" xlink:href="tlx-20260630.xsd#tlx_TherapeuticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019cf3d3-6adf-7192-98ae-8ef3850da395" xlink:to="loc_tlx_TherapeuticsMember_019cf3d3-6adf-7eb5-9dbd-f08f22022a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019cf3d3-6adf-72c2-9bb2-0bbe380b48c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019cf3d3-6adf-72de-ae31-f38ac2a6d16f" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019cf3d3-6adf-72c2-9bb2-0bbe380b48c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_019cf3d3-6adf-7d62-9635-84f3d0d12ad8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019cf3d3-6adf-72c2-9bb2-0bbe380b48c7" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_019cf3d3-6adf-7d62-9635-84f3d0d12ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromRoyalties_019cf3d3-6adf-7586-be11-d06099cde7dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019cf3d3-6adf-72c2-9bb2-0bbe380b48c7" xlink:to="loc_ifrs-full_RevenueFromRoyalties_019cf3d3-6adf-7586-be11-d06099cde7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_019cf3d3-6adf-77f2-a597-18de01c9df63" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019cf3d3-6adf-72c2-9bb2-0bbe380b48c7" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices_019cf3d3-6adf-77f2-a597-18de01c9df63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_RevenueFromResearchAndDevelopmentServices_019cf3d3-6adf-7a01-b40f-cb456cbbabef" xlink:href="tlx-20260630.xsd#tlx_RevenueFromResearchAndDevelopmentServices"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019cf3d3-6adf-72c2-9bb2-0bbe380b48c7" xlink:to="loc_tlx_RevenueFromResearchAndDevelopmentServices_019cf3d3-6adf-7a01-b40f-cb456cbbabef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_019cf3d3-6adf-7bbe-a191-1b3fb0f6f51c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019cf3d3-6adf-72c2-9bb2-0bbe380b48c7" xlink:to="loc_ifrs-full_Revenue_019cf3d3-6adf-7bbe-a191-1b3fb0f6f51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ProfitandlossinformationScheduleofEmploymentCostsDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ProfitandlossinformationScheduleofEmploymentCostsDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ProfitandlossinformationScheduleofEmploymentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-1632-7ac7-aadd-fff5f107a750" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WagesAndSalaries_019ed07f-1632-706d-8a38-c1368826f7b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WagesAndSalaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-1632-7ac7-aadd-fff5f107a750" xlink:to="loc_ifrs-full_WagesAndSalaries_019ed07f-1632-706d-8a38-c1368826f7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SalesCommissions_019ed07f-1632-7ee6-9566-63c36dc9d43f" xlink:href="tlx-20260630.xsd#tlx_SalesCommissions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-1632-7ac7-aadd-fff5f107a750" xlink:to="loc_tlx_SalesCommissions_019ed07f-1632-7ee6-9566-63c36dc9d43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019ed07f-1632-7bc3-9cb3-4f4e947b4e10" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-1632-7ac7-aadd-fff5f107a750" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019ed07f-1632-7bc3-9cb3-4f4e947b4e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_NonExecutiveDirectorsFees_019ed07f-1632-7ba0-9caf-caa3b0b9f092" xlink:href="tlx-20260630.xsd#tlx_NonExecutiveDirectorsFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-1632-7ac7-aadd-fff5f107a750" xlink:to="loc_tlx_NonExecutiveDirectorsFees_019ed07f-1632-7ba0-9caf-caa3b0b9f092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_019ed07f-1632-71cb-a2a9-3a36a170c3e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-1632-7ac7-aadd-fff5f107a750" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_019ed07f-1632-71cb-a2a9-3a36a170c3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ProfitandlossinformationNarrativeDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ProfitandlossinformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ProfitandlossinformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019fca8a-2109-7720-96e0-bb99525528b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_01a018db-f887-7c23-81e8-3ec87bfbe349" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019fca8a-2109-7720-96e0-bb99525528b3" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_01a018db-f887-7c23-81e8-3ec87bfbe349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_01a018db-f887-7bfd-851b-e20d290479fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_01a018db-f887-7c23-81e8-3ec87bfbe349" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_01a018db-f887-7bfd-851b-e20d290479fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_01a018db-f887-72e3-b66f-c7b267244849" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_01a018db-f887-7bfd-851b-e20d290479fb" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_01a018db-f887-72e3-b66f-c7b267244849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember_01a018db-f887-7bf4-8248-edc9e44c5424" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_01a018db-f887-72e3-b66f-c7b267244849" xlink:to="loc_ifrs-full_CostOfSalesMember_01a018db-f887-7bf4-8248-edc9e44c5424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_01a018db-f887-754c-aa81-f451656ac670" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_01a018db-f887-7c23-81e8-3ec87bfbe349" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_01a018db-f887-754c-aa81-f451656ac670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WagesAndSalaries_01a018db-f887-7ab7-929f-040530ba473b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WagesAndSalaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_01a018db-f887-754c-aa81-f451656ac670" xlink:to="loc_ifrs-full_WagesAndSalaries_01a018db-f887-7ab7-929f-040530ba473b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_NumberOfInitialTherapeuticPrograms_01a018db-8ec5-7824-9869-80fb42c1e845" xlink:href="tlx-20260630.xsd#tlx_NumberOfInitialTherapeuticPrograms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_01a018db-f887-754c-aa81-f451656ac670" xlink:to="loc_tlx_NumberOfInitialTherapeuticPrograms_01a018db-8ec5-7824-9869-80fb42c1e845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_019fca89-c4bf-73f6-910c-2f709f4f5569" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_01a018db-f887-754c-aa81-f451656ac670" xlink:to="loc_ifrs-full_OtherIncome_019fca89-c4bf-73f6-910c-2f709f4f5569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_GainLossOnRepurchaseOfConvertibleBonds_01a018dc-80a3-7f7d-9d25-dd9347c65c72" xlink:href="tlx-20260630.xsd#tlx_GainLossOnRepurchaseOfConvertibleBonds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_01a018db-f887-754c-aa81-f451656ac670" xlink:to="loc_tlx_GainLossOnRepurchaseOfConvertibleBonds_01a018dc-80a3-7f7d-9d25-dd9347c65c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ProfitandlossinformationScheduleofDepreciationandamortizationDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ProfitandlossinformationScheduleofDepreciationandamortizationDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ProfitandlossinformationScheduleofDepreciationandamortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-53a2-7e37-bfa8-21f9055f67cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationExpense_019ed07f-53a3-79a9-b675-603eeeebd1ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-53a2-7e37-bfa8-21f9055f67cf" xlink:to="loc_ifrs-full_AmortisationExpense_019ed07f-53a3-79a9-b675-603eeeebd1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationExpense_019ed07f-53a3-71d9-8f35-46304b3418c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-53a2-7e37-bfa8-21f9055f67cf" xlink:to="loc_ifrs-full_DepreciationExpense_019ed07f-53a3-71d9-8f35-46304b3418c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_019ed07f-53a3-7973-a6f7-788002f63b4e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-53a2-7e37-bfa8-21f9055f67cf" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_019ed07f-53a3-7973-a6f7-788002f63b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ProfitandlossinformationScheduleofOtherIncomeDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ProfitandlossinformationScheduleofOtherIncomeDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ProfitandlossinformationScheduleofOtherIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-b08d-7233-acb9-cb54d2a76cf4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_019fad3a-b3e9-78ba-a04e-9ee24ae68e50" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed07f-b08d-7233-acb9-cb54d2a76cf4" xlink:to="loc_ifrs-full_OtherIncome_019fad3a-b3e9-78ba-a04e-9ee24ae68e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ProfitandlossinformationScheduleofFinanceCostsDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ProfitandlossinformationScheduleofFinanceCostsDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ProfitandlossinformationScheduleofFinanceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_UnwindOfDiscount_019ed080-0995-7bca-b7cb-2ceb2677120f" xlink:href="tlx-20260630.xsd#tlx_UnwindOfDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:to="loc_tlx_UnwindOfDiscount_019ed080-0995-7bca-b7cb-2ceb2677120f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_019ed080-0995-7588-b100-b184e140f306" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_019ed080-0995-7588-b100-b184e140f306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBonds_019ed080-0995-75da-b210-2ba330e411c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBonds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:to="loc_ifrs-full_InterestExpenseOnBonds_019ed080-0995-75da-b210-2ba330e411c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_GainLossOnRepurchaseOfConvertibleBonds_019ed092-618e-72c8-b270-44e147777520" xlink:href="tlx-20260630.xsd#tlx_GainLossOnRepurchaseOfConvertibleBonds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:to="loc_tlx_GainLossOnRepurchaseOfConvertibleBonds_019ed092-618e-72c8-b270-44e147777520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_019ed080-0995-7ae5-97ef-d7c5d4a2b580" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:to="loc_ifrs-full_InterestExpense_019ed080-0995-7ae5-97ef-d7c5d4a2b580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankAndSimilarCharges_019ed080-0995-794c-893a-5af81a24f727" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankAndSimilarCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:to="loc_ifrs-full_BankAndSimilarCharges_019ed080-0995-794c-893a-5af81a24f727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_019ed080-0995-788b-a529-f15fdd5b751f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019ed080-0994-73d9-a88d-105bf1180a74" xlink:to="loc_ifrs-full_FinanceCosts_019ed080-0995-788b-a529-f15fdd5b751f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/IntangibleassetsDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#IntangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/IntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019cf3d3-6adf-75a1-8ef7-06547e4d9d08" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019cf3d3-6adf-7186-90dc-90e18df19e1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019cf3d3-6adf-75a1-8ef7-06547e4d9d08" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019cf3d3-6adf-7186-90dc-90e18df19e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_019cf3d3-6adf-7ae6-a327-6d0a8396efae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019cf3d3-6adf-7186-90dc-90e18df19e1d" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_019cf3d3-6adf-7ae6-a327-6d0a8396efae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_019cf3d3-6adf-7ae6-a327-6d0a8396efae" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_019cf3d3-6adf-7f84-a5dc-c76fa7d0dd4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:to="loc_ifrs-full_GoodwillMember_019cf3d3-6adf-7f84-a5dc-c76fa7d0dd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BrandNamesMember_019cf3d3-6adf-7234-878c-89a30baaf15b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BrandNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:to="loc_ifrs-full_BrandNamesMember_019cf3d3-6adf-7234-878c-89a30baaf15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_CustomerRelationshipsAndBrandsMember_019cf3d3-6adf-7c9e-9094-90a1ee8b554e" xlink:href="tlx-20260630.xsd#tlx_CustomerRelationshipsAndBrandsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:to="loc_tlx_CustomerRelationshipsAndBrandsMember_019cf3d3-6adf-7c9e-9094-90a1ee8b554e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_019cf3d3-6adf-7b69-af60-ee265ad9ae70" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:to="loc_ifrs-full_ComputerSoftwareMember_019cf3d3-6adf-7b69-af60-ee265ad9ae70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_019cf3d3-6adf-7d2a-835a-ac20f292366c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_019cf3d3-6adf-7d2a-835a-ac20f292366c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesMember_019cf3d3-6adf-7885-80bc-55fbd15a003f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_019cf3d3-6adf-7550-9b0f-71bcba2045e6" xlink:to="loc_ifrs-full_LicencesMember_019cf3d3-6adf-7885-80bc-55fbd15a003f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019cf3d3-6adf-7536-8c0b-026a601f8ddd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019cf3d3-6adf-7186-90dc-90e18df19e1d" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019cf3d3-6adf-7536-8c0b-026a601f8ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019cf3d3-6adf-7837-b185-2f9f28ae6d22" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019cf3d3-6adf-7536-8c0b-026a601f8ddd" xlink:to="loc_ifrs-full_CarryingAmountMember_019cf3d3-6adf-7837-b185-2f9f28ae6d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019cf3d3-6adf-7dc7-9f90-566481b6a50e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019cf3d3-6adf-7837-b185-2f9f28ae6d22" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019cf3d3-6adf-7dc7-9f90-566481b6a50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019cf3d3-6adf-7ba6-be3d-f46c749eeb22" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019cf3d3-6adf-7837-b185-2f9f28ae6d22" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019cf3d3-6adf-7ba6-be3d-f46c749eeb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019cf3d3-6adf-70df-98cd-5f40405aaee7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019cf3d3-6adf-7186-90dc-90e18df19e1d" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019cf3d3-6adf-70df-98cd-5f40405aaee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019cf3d3-6adf-70df-98cd-5f40405aaee7" xlink:to="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_019cf3d3-6adf-7457-8803-a53a480b95bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_019cf3d3-6adf-7457-8803-a53a480b95bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_019cf3d3-6adf-7d65-9ada-d0b7b1cf195f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_019cf3d3-6adf-7d65-9ada-d0b7b1cf195f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_019cf3d3-6adf-7b80-be93-2df7a2ad3423" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_019cf3d3-6adf-7b80-be93-2df7a2ad3423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughMeasurementPeriodAdjustmentsIntangibleAssetsAndGoodwill_019cf3d3-6adf-7a78-bea4-f88845e27fd3" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughMeasurementPeriodAdjustmentsIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_tlx_IncreaseDecreaseThroughMeasurementPeriodAdjustmentsIntangibleAssetsAndGoodwill_019cf3d3-6adf-7a78-bea4-f88845e27fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_019cf3d3-6adf-766d-b9db-b1894d37194f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_019cf3d3-6adf-766d-b9db-b1894d37194f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_019cf3d3-6adf-79e9-9be3-791212f15e60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_019cf3d3-6adf-79e9-9be3-791212f15e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_019cf3d3-6adf-7f53-90f5-17776da02448" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_019cf3d3-6adf-7f53-90f5-17776da02448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughChangesInProvisionsIntangibleAssetsAndGoodwill_019cf3d3-6adf-7067-84f5-8d2007e8233b" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughChangesInProvisionsIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_tlx_IncreaseDecreaseThroughChangesInProvisionsIntangibleAssetsAndGoodwill_019cf3d3-6adf-7067-84f5-8d2007e8233b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_019cf3d3-6adf-7d65-87c2-3da408873e96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_019cf3d3-6adf-7d65-87c2-3da408873e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_019cf3d3-6adf-7a1a-ab6f-55d8290f457f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019cf3d3-6adf-73cc-85e9-20e1e49dcc24" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_019cf3d3-6adf-7a1a-ab6f-55d8290f457f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#BorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/BorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract_019fc788-4145-73c0-8116-e4fd18f09261" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019fcd2e-c1d5-7a6c-a43c-8f32744bb67d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019fc788-4145-73c0-8116-e4fd18f09261" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019fcd2e-c1d5-7a6c-a43c-8f32744bb67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019fcd2f-48f5-7a83-b8a9-9273bdb31831" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019fcd2e-c1d5-7a6c-a43c-8f32744bb67d" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019fcd2f-48f5-7a83-b8a9-9273bdb31831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019fcd2f-6cab-723a-8677-f55d9f7403cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019fcd2f-48f5-7a83-b8a9-9273bdb31831" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019fcd2f-6cab-723a-8677-f55d9f7403cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ConvertibleNoteDue2031NewBondsMember_019fcd31-dc55-7e7e-b789-77228f06f31c" xlink:href="tlx-20260630.xsd#tlx_ConvertibleNoteDue2031NewBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019fcd2f-6cab-723a-8677-f55d9f7403cd" xlink:to="loc_tlx_ConvertibleNoteDue2031NewBondsMember_019fcd31-dc55-7e7e-b789-77228f06f31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ConvertibleNoteDue2029ExistingBondsMember_019fcd36-0896-7c22-9742-3fc7105456ce" xlink:href="tlx-20260630.xsd#tlx_ConvertibleNoteDue2029ExistingBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019fcd2f-6cab-723a-8677-f55d9f7403cd" xlink:to="loc_tlx_ConvertibleNoteDue2029ExistingBondsMember_019fcd36-0896-7c22-9742-3fc7105456ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019fcd2f-95bc-7bce-8f78-6c845b088923" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019fcd2e-c1d5-7a6c-a43c-8f32744bb67d" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019fcd2f-95bc-7bce-8f78-6c845b088923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BondsIssued_019fc7b5-b113-7fb5-bb47-258f818be78c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BondsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019fcd2f-95bc-7bce-8f78-6c845b088923" xlink:to="loc_ifrs-full_BondsIssued_019fc7b5-b113-7fb5-bb47-258f818be78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_019fc7ba-a1de-7967-a199-334008797d21" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019fcd2f-95bc-7bce-8f78-6c845b088923" xlink:to="loc_ifrs-full_BorrowingsInterestRate_019fc7ba-a1de-7967-a199-334008797d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_BondsRepurchased_019fc7d9-2fab-7898-98d3-cfb91995ca2d" xlink:href="tlx-20260630.xsd#tlx_BondsRepurchased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019fcd2f-95bc-7bce-8f78-6c845b088923" xlink:to="loc_tlx_BondsRepurchased_019fc7d9-2fab-7898-98d3-cfb91995ca2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_RepurchasedBondsAsAPercentageOfExistingBonds_019fc7df-6001-74c0-a395-373987d67af6" xlink:href="tlx-20260630.xsd#tlx_RepurchasedBondsAsAPercentageOfExistingBonds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019fcd2f-95bc-7bce-8f78-6c845b088923" xlink:to="loc_tlx_RepurchasedBondsAsAPercentageOfExistingBonds_019fc7df-6001-74c0-a395-373987d67af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7be8-ad28-546765018d61" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7be8-ad28-546765018d61" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentSecuredBankLoansReceivedAndCurrentPortionOfNoncurrentSecuredBankLoansReceived_019cf3d3-6bac-75a9-bd7c-6f89d7a28d8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentSecuredBankLoansReceivedAndCurrentPortionOfNoncurrentSecuredBankLoansReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:to="loc_ifrs-full_CurrentSecuredBankLoansReceivedAndCurrentPortionOfNoncurrentSecuredBankLoansReceived_019cf3d3-6bac-75a9-bd7c-6f89d7a28d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SecuredWorkingCapitalFacilityCurrent_019cf3d3-6bac-7f1b-a9cc-82f8aff56ac3" xlink:href="tlx-20260630.xsd#tlx_SecuredWorkingCapitalFacilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:to="loc_tlx_SecuredWorkingCapitalFacilityCurrent_019cf3d3-6bac-7f1b-a9cc-82f8aff56ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SecuredBorrowingsCurrent_019cf3d3-6bac-79d2-8e64-2a8c800116c4" xlink:href="tlx-20260630.xsd#tlx_SecuredBorrowingsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:to="loc_tlx_SecuredBorrowingsCurrent_019cf3d3-6bac-79d2-8e64-2a8c800116c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued_019cf3d3-6bac-73ef-8519-ec5c7110047f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:to="loc_ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued_019cf3d3-6bac-73ef-8519-ec5c7110047f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_UnsecuredBorrowingsCurrent_019cf3d3-6bac-7199-95c1-5332f4c8798a" xlink:href="tlx-20260630.xsd#tlx_UnsecuredBorrowingsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:to="loc_tlx_UnsecuredBorrowingsCurrent_019cf3d3-6bac-7199-95c1-5332f4c8798a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowings_019cf3d3-6bac-7a48-87a2-8d0de3dc715e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7ca2-a743-693417fd22a7" xlink:to="loc_ifrs-full_ShorttermBorrowings_019cf3d3-6bac-7a48-87a2-8d0de3dc715e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-7be8-ad28-546765018d61" xlink:to="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfNoncurrentSecuredBankLoansReceived_019cf3d3-6bac-7202-9b28-c15c25f107d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentSecuredBankLoansReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:to="loc_ifrs-full_NoncurrentPortionOfNoncurrentSecuredBankLoansReceived_019cf3d3-6bac-7202-9b28-c15c25f107d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SecuredWorkingCapitalFacilityNonCurrent_019cf3d3-6bac-7dca-872a-70dd2e39cf4b" xlink:href="tlx-20260630.xsd#tlx_SecuredWorkingCapitalFacilityNonCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:to="loc_tlx_SecuredWorkingCapitalFacilityNonCurrent_019cf3d3-6bac-7dca-872a-70dd2e39cf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SecuredBorrowingsNonCurrent_019cf3d3-6bac-7030-8156-f72e2476d1a1" xlink:href="tlx-20260630.xsd#tlx_SecuredBorrowingsNonCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:to="loc_tlx_SecuredBorrowingsNonCurrent_019cf3d3-6bac-7030-8156-f72e2476d1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_019cf3d3-6bac-7c60-8b0c-7652bff406bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:to="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_019cf3d3-6bac-7c60-8b0c-7652bff406bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_UnsecuredBorrowingsNonCurrent_019cf3d3-6bac-787e-9f3b-5ba2ae59ba7c" xlink:href="tlx-20260630.xsd#tlx_UnsecuredBorrowingsNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:to="loc_tlx_UnsecuredBorrowingsNonCurrent_019cf3d3-6bac-787e-9f3b-5ba2ae59ba7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_019cf3d3-6bac-7f24-b60e-811579ffb112" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_019cf3d3-6bac-7995-a8c7-3b949bb8934d" xlink:to="loc_ifrs-full_LongtermBorrowings_019cf3d3-6bac-7f24-b60e-811579ffb112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/BorrowingsScheduleofConvertibleBondsDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#BorrowingsScheduleofConvertibleBondsDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/BorrowingsScheduleofConvertibleBondsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-701d-b5f5-e643da25a48e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019cf3d3-6bac-7ef5-b0b6-809466325962" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019cf3d3-6bac-701d-b5f5-e643da25a48e" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019cf3d3-6bac-7ef5-b0b6-809466325962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019cf3d3-6bac-77d6-afd0-a802303b8525" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019cf3d3-6bac-7ef5-b0b6-809466325962" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019cf3d3-6bac-77d6-afd0-a802303b8525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019cf3d3-6bac-7330-be38-58aca4b8a1fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019cf3d3-6bac-77d6-afd0-a802303b8525" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019cf3d3-6bac-7330-be38-58aca4b8a1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ConvertibleBondsMember_019cf3d3-6bac-79ad-b650-99a56d291532" xlink:href="tlx-20260630.xsd#tlx_ConvertibleBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019cf3d3-6bac-7330-be38-58aca4b8a1fd" xlink:to="loc_tlx_ConvertibleBondsMember_019cf3d3-6bac-79ad-b650-99a56d291532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ConvertibleNoteDue2029ExistingBondsMember_01a01199-4ae1-782f-af3a-be384359ec82" xlink:href="tlx-20260630.xsd#tlx_ConvertibleNoteDue2029ExistingBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019cf3d3-6bac-7330-be38-58aca4b8a1fd" xlink:to="loc_tlx_ConvertibleNoteDue2029ExistingBondsMember_01a01199-4ae1-782f-af3a-be384359ec82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ConvertibleNoteDue2031NewBondsMember_01a01199-7b4d-7f35-b181-0846e4ac0aaa" xlink:href="tlx-20260630.xsd#tlx_ConvertibleNoteDue2031NewBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019cf3d3-6bac-7330-be38-58aca4b8a1fd" xlink:to="loc_tlx_ConvertibleNoteDue2031NewBondsMember_01a01199-7b4d-7f35-b181-0846e4ac0aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019cf3d3-6bac-7ef5-b0b6-809466325962" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019cf3d3-6bac-7547-896b-fb2be8f6a151" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_Borrowings_019cf3d3-6bac-7547-896b-fb2be8f6a151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_UnwindOfDiscount_019cf3d3-6bac-78f9-9be9-18e2a108a6e2" xlink:href="tlx-20260630.xsd#tlx_UnwindOfDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_tlx_UnwindOfDiscount_019cf3d3-6bac-78f9-9be9-18e2a108a6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBonds_019cf3d3-6bac-7098-8a64-bc1b0e5b98c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBonds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_InterestExpenseOnBonds_019cf3d3-6bac-7098-8a64-bc1b0e5b98c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_InterestPaidOnConvertibleBonds_019cf3d3-6bac-78a2-b592-4319c2b3db08" xlink:href="tlx-20260630.xsd#tlx_InterestPaidOnConvertibleBonds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_tlx_InterestPaidOnConvertibleBonds_019cf3d3-6bac-78a2-b592-4319c2b3db08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_RepurchaseOfConvertibleBonds_019ed115-9524-7be2-a482-38d5fde1b5d5" xlink:href="tlx-20260630.xsd#tlx_RepurchaseOfConvertibleBonds"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_tlx_RepurchaseOfConvertibleBonds_019ed115-9524-7be2-a482-38d5fde1b5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_019cf3d3-6bac-73ac-aca7-8870945e6168" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_NotionalAmount_019cf3d3-6bac-73ac-aca7-8870945e6168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_019cf3d3-6bac-7503-9bb8-02bbab39dbef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_019cf3d3-6bac-7503-9bb8-02bbab39dbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_OtherEquitySecuritiesValueOfConversionRights_019cf3d3-6bac-7d54-b23d-0953d688cec1" xlink:href="tlx-20260630.xsd#tlx_OtherEquitySecuritiesValueOfConversionRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_tlx_OtherEquitySecuritiesValueOfConversionRights_019cf3d3-6bac-7d54-b23d-0953d688cec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseInForeignExchangeDifferencesInConvertibleBonds_019cf3d3-6bac-7ed3-b807-8e18f8e99bbb" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseInForeignExchangeDifferencesInConvertibleBonds"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_tlx_IncreaseDecreaseInForeignExchangeDifferencesInConvertibleBonds_019cf3d3-6bac-7ed3-b807-8e18f8e99bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019cf3d3-6bac-75ab-a375-1d5690230174" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_Borrowings_019cf3d3-6bac-75ab-a375-1d5690230174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowings_019cf3d3-6bac-7319-b857-bbc31460c539" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_ShorttermBorrowings_019cf3d3-6bac-7319-b857-bbc31460c539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_019cf3d3-6bac-79a1-9a4e-ab839d3415a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_LongtermBorrowings_019cf3d3-6bac-79a1-9a4e-ab839d3415a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019cf3d3-6bac-75ff-9bf2-f9862bcfbc76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019cf3d3-6bac-717f-8773-414fb368b773" xlink:to="loc_ifrs-full_Borrowings_019cf3d3-6bac-75ff-9bf2-f9862bcfbc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/BorrowingsScheduleofFairValueHierarchyDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#BorrowingsScheduleofFairValueHierarchyDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/BorrowingsScheduleofFairValueHierarchyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAbstract_019fb8e5-49b0-7edf-b11d-1c7ea4838504" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_019fb8e8-f453-771d-8f74-9292d9ec949d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsAbstract_019fb8e5-49b0-7edf-b11d-1c7ea4838504" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_019fb8e8-f453-771d-8f74-9292d9ec949d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_019fb8e9-2c8b-75ad-9e46-ad427d80e10c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_019fb8e8-f453-771d-8f74-9292d9ec949d" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_019fb8e9-2c8b-75ad-9e46-ad427d80e10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_019fb8e9-ab62-77f0-a938-7ebb32e00cff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_019fb8e9-2c8b-75ad-9e46-ad427d80e10c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_019fb8e9-ab62-77f0-a938-7ebb32e00cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_BankLoansMember_019fb8ea-2b2e-7083-aec2-7c6d6325a662" xlink:href="tlx-20260630.xsd#tlx_BankLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_019fb8e9-ab62-77f0-a938-7ebb32e00cff" xlink:to="loc_tlx_BankLoansMember_019fb8ea-2b2e-7083-aec2-7c6d6325a662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ConvertibleBondsMember_019fb8ea-78d4-74c8-bcec-5e96461c8fb7" xlink:href="tlx-20260630.xsd#tlx_ConvertibleBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_019fb8e9-ab62-77f0-a938-7ebb32e00cff" xlink:to="loc_tlx_ConvertibleBondsMember_019fb8ea-78d4-74c8-bcec-5e96461c8fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_019fb8ee-4a3a-75e1-b756-c0343faa6380" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_019fb8e8-f453-771d-8f74-9292d9ec949d" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_019fb8ee-4a3a-75e1-b756-c0343faa6380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_019fc737-8b69-702c-b75a-1a89a87e13ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_019fb8ee-4a3a-75e1-b756-c0343faa6380" xlink:to="loc_ifrs-full_FinancialLiabilities_019fc737-8b69-702c-b75a-1a89a87e13ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019fc737-135e-768d-9c15-04f7113994fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_019fb8ee-4a3a-75e1-b756-c0343faa6380" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019fc737-135e-768d-9c15-04f7113994fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ContractualmaturitiesoffinancialliabilitiesDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ContractualmaturitiesoffinancialliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ContractualmaturitiesoffinancialliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7087-89da-e048f64bb37a" xlink:href="tlx-20260630.xsd#tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_019ed0fe-89e1-70eb-a4cd-ff56d3916a6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_MaturityAnalysisForNonDerivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7087-89da-e048f64bb37a" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_019ed0fe-89e1-70eb-a4cd-ff56d3916a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_019ed0fe-89e1-7566-b04b-5dcbd4b8bf6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_019ed0fe-89e1-70eb-a4cd-ff56d3916a6b" xlink:to="loc_ifrs-full_MaturityAxis_019ed0fe-89e1-7566-b04b-5dcbd4b8bf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019ed0fe-89e1-7e08-834f-e2ab8697f317" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_019ed0fe-89e1-7566-b04b-5dcbd4b8bf6e" xlink:to="loc_ifrs-full_MaturityDomain_019ed0fe-89e1-7e08-834f-e2ab8697f317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanSixMonthsMember_019ed0fe-89e1-77e8-8389-03af62461973" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanSixMonthsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019ed0fe-89e1-7e08-834f-e2ab8697f317" xlink:to="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanSixMonthsMember_019ed0fe-89e1-77e8-8389-03af62461973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_019ed0fe-89e1-7712-b364-a9410df3866e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019ed0fe-89e1-7e08-834f-e2ab8697f317" xlink:to="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_019ed0fe-89e1-7712-b364-a9410df3866e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019ed0fe-89e1-7aca-ae57-1ea7ba24e48f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019ed0fe-89e1-7e08-834f-e2ab8697f317" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019ed0fe-89e1-7aca-ae57-1ea7ba24e48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_019ed0fe-89e1-74e3-95e6-72037e07d732" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019ed0fe-89e1-7e08-834f-e2ab8697f317" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_019ed0fe-89e1-74e3-95e6-72037e07d732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_019ed0fe-89e1-72a6-8669-0e96b4e478d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_019ed0fe-89e1-70eb-a4cd-ff56d3916a6b" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_019ed0fe-89e1-72a6-8669-0e96b4e478d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_019ed0fe-89e1-72a6-8669-0e96b4e478d6" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019ed0fe-89e1-7a4b-9e90-bdb53be5bc18" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019ed0fe-89e1-7a4b-9e90-bdb53be5bc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_019ed0fe-89e1-7bb3-a98d-22fc55e5990c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_019ed0fe-89e1-7bb3-a98d-22fc55e5990c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_OtherNonCurrentLiabilitiesUndiscountedCashFlows_019ed0fe-89e1-7cdf-8a8d-dc853b68c887" xlink:href="tlx-20260630.xsd#tlx_OtherNonCurrentLiabilitiesUndiscountedCashFlows"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_tlx_OtherNonCurrentLiabilitiesUndiscountedCashFlows_019ed0fe-89e1-7cdf-8a8d-dc853b68c887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_019ed0fe-89e1-735d-90bd-ed55fe8f07f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_019ed0fe-89e1-735d-90bd-ed55fe8f07f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019ed0fe-89e1-7358-bcec-e842358eb656" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019ed0fe-89e1-7358-bcec-e842358eb656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019ed0fe-89e1-778b-a8de-da3d9eeb0151" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_Borrowings_019ed0fe-89e1-778b-a8de-da3d9eeb0151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_019ed0fe-89e1-720f-92a1-27c9db71b4a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_019ed0fe-89e1-720f-92a1-27c9db71b4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_019ed0fe-89e1-74e0-8956-648b90d7b931" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_LeaseLiabilities_019ed0fe-89e1-74e0-8956-648b90d7b931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_GovernmentGrantLiabilityUndiscountedCashFlows_019ed0fe-89e1-7878-ad2a-af07219b14cb" xlink:href="tlx-20260630.xsd#tlx_GovernmentGrantLiabilityUndiscountedCashFlows"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_tlx_GovernmentGrantLiabilityUndiscountedCashFlows_019ed0fe-89e1-7878-ad2a-af07219b14cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GovernmentGrants_019ed0fe-89e1-7150-81fa-dfe20555c1a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_GovernmentGrants_019ed0fe-89e1-7150-81fa-dfe20555c1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ContingentConsiderationLiabilityUndiscountedCashFlows_019ed0fe-89e1-7927-bc7b-58606cdbb288" xlink:href="tlx-20260630.xsd#tlx_ContingentConsiderationLiabilityUndiscountedCashFlows"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_tlx_ContingentConsiderationLiabilityUndiscountedCashFlows_019ed0fe-89e1-7927-bc7b-58606cdbb288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ContingentConsideration_019ed0fe-89e1-7e2c-a8ed-8720ac3ceb14" xlink:href="tlx-20260630.xsd#tlx_ContingentConsideration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_tlx_ContingentConsideration_019ed0fe-89e1-7e2c-a8ed-8720ac3ceb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_019ed0fe-89e1-793f-a3fd-8e2fb064bd45" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_019ed0fe-89e1-793f-a3fd-8e2fb064bd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_019ed0fe-89e1-73a4-a6fb-2ede3657d63b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract_019ed0fe-89e1-7e9c-9029-657d877598cd" xlink:to="loc_ifrs-full_FinancialLiabilities_019ed0fe-89e1-73a4-a6fb-2ede3657d63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/EquityScheduleofShareCapitalDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#EquityScheduleofShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/EquityScheduleofShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-7582-81e4-a09ebf177499" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7fb5-9957-79cd45daf362" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-7582-81e4-a09ebf177499" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7fb5-9957-79cd45daf362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-71f9-8bb9-e38f9307048f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7fb5-9957-79cd45daf362" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-71f9-8bb9-e38f9307048f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-73ca-9c70-4736c17d4197" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-71f9-8bb9-e38f9307048f" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-73ca-9c70-4736c17d4197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019cf3d3-6bad-7f1d-bb2a-f1e96a0c2991" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-73ca-9c70-4736c17d4197" xlink:to="loc_ifrs-full_IssuedCapitalMember_019cf3d3-6bad-7f1d-bb2a-f1e96a0c2991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_019cf3d3-6bad-7454-81ec-36fc0f4b9e83" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7fb5-9957-79cd45daf362" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_019cf3d3-6bad-7454-81ec-36fc0f4b9e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_019cf3d3-6bad-7cba-b413-c451687be7da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_019cf3d3-6bad-7454-81ec-36fc0f4b9e83" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_019cf3d3-6bad-7cba-b413-c451687be7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DedicaidGmbHMember_019cf3d3-6bad-73c3-9433-5f3a5738101c" xlink:href="tlx-20260630.xsd#tlx_DedicaidGmbHMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_019cf3d3-6bad-7cba-b413-c451687be7da" xlink:to="loc_tlx_DedicaidGmbHMember_019cf3d3-6bad-73c3-9433-5f3a5738101c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_LightpointMedicalMember_019cf3d3-6bad-739a-8924-5bea6bd8b36b" xlink:href="tlx-20260630.xsd#tlx_LightpointMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_019cf3d3-6bad-7cba-b413-c451687be7da" xlink:to="loc_tlx_LightpointMedicalMember_019cf3d3-6bad-739a-8924-5bea6bd8b36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ImaginAbIncMember_019cf3d3-6bad-7bbb-8d42-a953f9e462b8" xlink:href="tlx-20260630.xsd#tlx_ImaginAbIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_019cf3d3-6bad-7cba-b413-c451687be7da" xlink:to="loc_tlx_ImaginAbIncMember_019cf3d3-6bad-7bbb-8d42-a953f9e462b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7289-8079-d5e52fcee79e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7fb5-9957-79cd45daf362" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7289-8079-d5e52fcee79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_019cf3d3-6bad-7838-a6a3-48631f630321" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7289-8079-d5e52fcee79e" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_019cf3d3-6bad-7838-a6a3-48631f630321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_NumberOfSharesAbstract_019cf3d3-6bad-7873-b11c-e987faa68aef" xlink:href="tlx-20260630.xsd#tlx_NumberOfSharesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_019cf3d3-6bad-7838-a6a3-48631f630321" xlink:to="loc_tlx_NumberOfSharesAbstract_019cf3d3-6bad-7873-b11c-e987faa68aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_019cf3d3-6bad-7031-bd2e-be8d33906f62" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_NumberOfSharesAbstract_019cf3d3-6bad-7873-b11c-e987faa68aef" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_019cf3d3-6bad-7031-bd2e-be8d33906f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseSharesIssuedThroughExerciseOfShareOptionsAndWarrants_019cf3d3-6bad-7da7-b617-57dd92879c6c" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseSharesIssuedThroughExerciseOfShareOptionsAndWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_NumberOfSharesAbstract_019cf3d3-6bad-7873-b11c-e987faa68aef" xlink:to="loc_tlx_IncreaseDecreaseSharesIssuedThroughExerciseOfShareOptionsAndWarrants_019cf3d3-6bad-7da7-b617-57dd92879c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseInNumberOfSharesIssued_019cf3d3-6bad-737e-a7a4-0d0966e85da5" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseInNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_NumberOfSharesAbstract_019cf3d3-6bad-7873-b11c-e987faa68aef" xlink:to="loc_tlx_IncreaseDecreaseInNumberOfSharesIssued_019cf3d3-6bad-737e-a7a4-0d0966e85da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_019cf3d3-6bad-7ebc-83da-aa6010f721f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_NumberOfSharesAbstract_019cf3d3-6bad-7873-b11c-e987faa68aef" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_019cf3d3-6bad-7ebc-83da-aa6010f721f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ValueOfShareholdingAbstract_019cf3d3-6bad-76e2-ba0f-9fab375d4b31" xlink:href="tlx-20260630.xsd#tlx_ValueOfShareholdingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_019cf3d3-6bad-7838-a6a3-48631f630321" xlink:to="loc_tlx_ValueOfShareholdingAbstract_019cf3d3-6bad-76e2-ba0f-9fab375d4b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_019cf3d3-6bad-77fe-a4ea-572fed39ff25" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ValueOfShareholdingAbstract_019cf3d3-6bad-76e2-ba0f-9fab375d4b31" xlink:to="loc_ifrs-full_IssuedCapital_019cf3d3-6bad-77fe-a4ea-572fed39ff25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SharesIssuedThroughExerciseOfShareOptionsAndWarrants_019cf3d3-6bad-7a6a-9829-6ff2470dbb37" xlink:href="tlx-20260630.xsd#tlx_SharesIssuedThroughExerciseOfShareOptionsAndWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ValueOfShareholdingAbstract_019cf3d3-6bad-76e2-ba0f-9fab375d4b31" xlink:to="loc_tlx_SharesIssuedThroughExerciseOfShareOptionsAndWarrants_019cf3d3-6bad-7a6a-9829-6ff2470dbb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019cf3d3-6bad-7b34-859c-fa6c91d8dcd8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ValueOfShareholdingAbstract_019cf3d3-6bad-76e2-ba0f-9fab375d4b31" xlink:to="loc_ifrs-full_IssueOfEquity_019cf3d3-6bad-7b34-859c-fa6c91d8dcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_019cf3d3-6bad-7b0c-8015-02834652f524" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_ValueOfShareholdingAbstract_019cf3d3-6bad-76e2-ba0f-9fab375d4b31" xlink:to="loc_ifrs-full_IssuedCapital_019cf3d3-6bad-7b0c-8015-02834652f524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_VolumeWeightedAveragePeriod_019cf3d3-6bad-79d6-99eb-d980bcf929ed" xlink:href="tlx-20260630.xsd#tlx_VolumeWeightedAveragePeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7289-8079-d5e52fcee79e" xlink:to="loc_tlx_VolumeWeightedAveragePeriod_019cf3d3-6bad-79d6-99eb-d980bcf929ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_VolumeWeightedAveragePriceOfEquityInstruments_019cf3d3-6bad-7967-a3e4-5b81a13f9fee" xlink:href="tlx-20260630.xsd#tlx_VolumeWeightedAveragePriceOfEquityInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7289-8079-d5e52fcee79e" xlink:to="loc_tlx_VolumeWeightedAveragePriceOfEquityInstruments_019cf3d3-6bad-7967-a3e4-5b81a13f9fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_019cf3d3-6bad-724d-a128-43fce7e94405" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7289-8079-d5e52fcee79e" xlink:to="loc_ifrs-full_ParValuePerShare_019cf3d3-6bad-724d-a128-43fce7e94405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DeferredConsiderationIndemnityPeriod_019f5eff-67d9-73e2-a852-76005d2c4208" xlink:href="tlx-20260630.xsd#tlx_DeferredConsiderationIndemnityPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7289-8079-d5e52fcee79e" xlink:to="loc_tlx_DeferredConsiderationIndemnityPeriod_019f5eff-67d9-73e2-a852-76005d2c4208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#EquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/EquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-7f8f-97f4-6160272da765" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7001-b9b1-486b46f107d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-7f8f-97f4-6160272da765" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7001-b9b1-486b46f107d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019cf3d3-6bad-7f38-98be-b45b8279439b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7001-b9b1-486b46f107d7" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019cf3d3-6bad-7f38-98be-b45b8279439b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019cf3d3-6bad-7ecd-85d4-58376f4977c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019cf3d3-6bad-7f38-98be-b45b8279439b" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019cf3d3-6bad-7ecd-85d4-58376f4977c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019cf3d3-6bad-72ba-8086-51235ca56b4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019cf3d3-6bad-7ecd-85d4-58376f4977c5" xlink:to="loc_ifrs-full_OrdinarySharesMember_019cf3d3-6bad-72ba-8086-51235ca56b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-7ff0-bc95-0cb3139e9bbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7001-b9b1-486b46f107d7" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-7ff0-bc95-0cb3139e9bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-77bf-bcfe-9b3361d4e11d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-7ff0-bc95-0cb3139e9bbd" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-77bf-bcfe-9b3361d4e11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019cf3d3-6bad-724e-9746-807a71b6a490" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-77bf-bcfe-9b3361d4e11d" xlink:to="loc_ifrs-full_IssuedCapitalMember_019cf3d3-6bad-724e-9746-807a71b6a490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7ddc-9fd2-1c46c5e34d55" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7001-b9b1-486b46f107d7" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7ddc-9fd2-1c46c5e34d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_019cf3d3-6bad-78a4-a4b1-aec940c75b74" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7ddc-9fd2-1c46c5e34d55" xlink:to="loc_ifrs-full_WeightedAverageShares_019cf3d3-6bad-78a4-a4b1-aec940c75b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/EquityScheduleofOtherReservesDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#EquityScheduleofOtherReservesDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/EquityScheduleofOtherReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-75f6-acf0-1c554057a7e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7b5c-8633-57691f811b70" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019cf3d3-6bad-75f6-acf0-1c554057a7e8" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7b5c-8633-57691f811b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-74fc-89e8-ba9e66e72c5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7b5c-8633-57691f811b70" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-74fc-89e8-ba9e66e72c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-7037-ae48-83973abc6f93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019cf3d3-6bad-74fc-89e8-ba9e66e72c5e" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-7037-ae48-83973abc6f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_019cf3d3-6bad-7325-aa45-070627612cc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-7037-ae48-83973abc6f93" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_019cf3d3-6bad-7325-aa45-070627612cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_019cf3d3-6bad-73c5-948f-c2993c1ded99" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-7037-ae48-83973abc6f93" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_019cf3d3-6bad-73c5-948f-c2993c1ded99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_019cf3d3-6bad-7976-bd76-dcdd2ab7a7ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-7037-ae48-83973abc6f93" xlink:to="loc_ifrs-full_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_019cf3d3-6bad-7976-bd76-dcdd2ab7a7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_019cf3d3-6bad-7998-a001-702229028a0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019cf3d3-6bad-7037-ae48-83973abc6f93" xlink:to="loc_ifrs-full_OtherReservesMember_019cf3d3-6bad-7998-a001-702229028a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7d59-8afa-0987786fcdee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019cf3d3-6bad-7b5c-8633-57691f811b70" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7d59-8afa-0987786fcdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:href="tlx-20260630.xsd#tlx_OtherReservesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019cf3d3-6bad-7d59-8afa-0987786fcdee" xlink:to="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019cf3d3-6bad-7bd7-9a3f-5f385ba9c6b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_ifrs-full_Equity_019cf3d3-6bad-7bd7-9a3f-5f385ba9c6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_019cf3d3-6bad-767a-a881-a999aa03836f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_019cf3d3-6bad-767a-a881-a999aa03836f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019cf3d3-6bad-7481-befc-5c49dadf1d1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_ifrs-full_ComprehensiveIncome_019cf3d3-6bad-7481-befc-5c49dadf1d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019cf3d3-6bad-7773-a88c-d8b794029085" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019cf3d3-6bad-7773-a88c-d8b794029085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughShareBasedPaymentTransactionsAssociatedWithAcquisitionsEquity_019f638d-8a2d-734f-8911-caf5f1e9a765" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughShareBasedPaymentTransactionsAssociatedWithAcquisitionsEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_tlx_IncreaseDecreaseThroughShareBasedPaymentTransactionsAssociatedWithAcquisitionsEquity_019f638d-8a2d-734f-8911-caf5f1e9a765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughTransferOnSatisfactionOfAcquisitionPerformanceRightsEquity_019f638d-da5f-7a49-bf60-d7a6b19639e1" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughTransferOnSatisfactionOfAcquisitionPerformanceRightsEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_tlx_IncreaseDecreaseThroughTransferOnSatisfactionOfAcquisitionPerformanceRightsEquity_019f638d-da5f-7a49-bf60-d7a6b19639e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_IncreaseDecreaseThroughTransferOnExerciseOfOptionsEquity_019cf3d3-6bad-790a-925e-fc845affa083" xlink:href="tlx-20260630.xsd#tlx_IncreaseDecreaseThroughTransferOnExerciseOfOptionsEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_tlx_IncreaseDecreaseThroughTransferOnExerciseOfOptionsEquity_019cf3d3-6bad-790a-925e-fc845affa083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInEquity_019cf3d3-6bad-70ec-8b4a-c3aeb829052a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_ifrs-full_ChangesInEquity_019cf3d3-6bad-70ec-8b4a-c3aeb829052a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019cf3d3-6bad-7bb0-9731-ff3dbb726dc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_OtherReservesAbstract_019cf3d3-6bad-78ff-a46a-3d19dd6efcdd" xlink:to="loc_ifrs-full_Equity_019cf3d3-6bad-7bb0-9731-ff3dbb726dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/FairvalueDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#FairvalueDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/FairvalueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tlx_FairValueAbstract_019fc73d-4d54-797b-932b-a2ed31a0c4db" xlink:href="tlx-20260630.xsd#tlx_FairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfFairValueOfAssetsAndLiabilitiesTable_019fc74c-75ee-76c3-afef-126026c0bee3" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfFairValueOfAssetsAndLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_FairValueAbstract_019fc73d-4d54-797b-932b-a2ed31a0c4db" xlink:to="loc_tlx_DisclosureOfFairValueOfAssetsAndLiabilitiesTable_019fc74c-75ee-76c3-afef-126026c0bee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019fc74c-b373-7ca2-a60a-5a2b6dca2c38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_DisclosureOfFairValueOfAssetsAndLiabilitiesTable_019fc74c-75ee-76c3-afef-126026c0bee3" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019fc74c-b373-7ca2-a60a-5a2b6dca2c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019fc74c-d587-7e61-95cc-cc6ba86ed790" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019fc74c-b373-7ca2-a60a-5a2b6dca2c38" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019fc74c-d587-7e61-95cc-cc6ba86ed790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_019fc74d-1339-750e-b5a5-79de3cd16503" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019fc74c-d587-7e61-95cc-cc6ba86ed790" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_019fc74d-1339-750e-b5a5-79de3cd16503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_019fc74d-4a1d-7e97-8d65-fbc1836d4087" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019fc74c-d587-7e61-95cc-cc6ba86ed790" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_019fc74d-4a1d-7e97-8d65-fbc1836d4087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksAxis_019fcccc-1b98-70b7-bc88-51e6d6851e7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_DisclosureOfFairValueOfAssetsAndLiabilitiesTable_019fc74c-75ee-76c3-afef-126026c0bee3" xlink:to="loc_ifrs-full_TypesOfRisksAxis_019fcccc-1b98-70b7-bc88-51e6d6851e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfRisksDomain_019fcccc-3d75-7795-ba9e-f0eb87467bc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_019fcccc-1b98-70b7-bc88-51e6d6851e7b" xlink:to="loc_ifrs-full_TypesOfRisksDomain_019fcccc-3d75-7795-ba9e-f0eb87467bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityPriceRiskMember_019fcccc-7efe-7c85-9aa6-5767b34619e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityPriceRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_019fcccc-3d75-7795-ba9e-f0eb87467bc2" xlink:to="loc_ifrs-full_EquityPriceRiskMember_019fcccc-7efe-7c85-9aa6-5767b34619e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DiscountRateRiskMember_019fccce-aed2-7d34-99ec-759e2cba4865" xlink:href="tlx-20260630.xsd#tlx_DiscountRateRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_019fcccc-3d75-7795-ba9e-f0eb87467bc2" xlink:to="loc_tlx_DiscountRateRiskMember_019fccce-aed2-7d34-99ec-759e2cba4865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SalesVolumeRiskMember_019fccd5-25f2-7308-94c1-47a90a1d10cd" xlink:href="tlx-20260630.xsd#tlx_SalesVolumeRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_019fcccc-3d75-7795-ba9e-f0eb87467bc2" xlink:to="loc_tlx_SalesVolumeRiskMember_019fccd5-25f2-7308-94c1-47a90a1d10cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019fc74f-4875-7fae-a2dc-c731667b8958" xlink:href="tlx-20260630.xsd#tlx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_DisclosureOfFairValueOfAssetsAndLiabilitiesTable_019fc74c-75ee-76c3-afef-126026c0bee3" xlink:to="loc_tlx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019fc74f-4875-7fae-a2dc-c731667b8958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_019fc754-8504-7278-8196-002b798c4b32" xlink:href="tlx-20260630.xsd#tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019fc74f-4875-7fae-a2dc-c731667b8958" xlink:to="loc_tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent_019fc754-8504-7278-8196-002b798c4b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnOtherComprehensiveIncome_019fc752-2122-7c73-8ed1-ccc39dbe799e" xlink:href="tlx-20260630.xsd#tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnOtherComprehensiveIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019fc74f-4875-7fae-a2dc-c731667b8958" xlink:to="loc_tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnOtherComprehensiveIncome_019fc752-2122-7c73-8ed1-ccc39dbe799e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnPreTaxEarnings_019fc759-a108-701a-b148-67b164ae9af2" xlink:href="tlx-20260630.xsd#tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnPreTaxEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019fc74f-4875-7fae-a2dc-c731667b8958" xlink:to="loc_tlx_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnPreTaxEarnings_019fc759-a108-701a-b148-67b164ae9af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://telixpharma.com/role/ContingentliabilitiesandCommitmentsDetails" xlink:type="simple" xlink:href="tlx-20260630.xsd#ContingentliabilitiesandCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://telixpharma.com/role/ContingentliabilitiesandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_019cf3d3-6c81-744d-bffb-47cfda8f48bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_CommitmentsAndContingenciesTable_019fb8a9-f933-7aa1-83ad-29e274cabef0" xlink:href="tlx-20260630.xsd#tlx_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_019cf3d3-6c81-744d-bffb-47cfda8f48bd" xlink:to="loc_tlx_CommitmentsAndContingenciesTable_019fb8a9-f933-7aa1-83ad-29e274cabef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_019fb8a9-f933-7e6f-be36-cd3a501327cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_CommitmentsAndContingenciesTable_019fb8a9-f933-7aa1-83ad-29e274cabef0" xlink:to="loc_ifrs-full_MaturityAxis_019fb8a9-f933-7e6f-be36-cd3a501327cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019fb8a9-f933-7281-8873-6f09c477c393" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_019fb8a9-f933-7e6f-be36-cd3a501327cc" xlink:to="loc_ifrs-full_MaturityDomain_019fb8a9-f933-7281-8873-6f09c477c393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_019fb8a9-f933-7d1b-a9e9-f8f2db51b10a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019fb8a9-f933-7281-8873-6f09c477c393" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_019fb8a9-f933-7d1b-a9e9-f8f2db51b10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember_019fb8a9-f933-7e20-9976-d1a2950bc58a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019fb8a9-f933-7281-8873-6f09c477c393" xlink:to="loc_ifrs-full_LaterThanOneYearMember_019fb8a9-f933-7e20-9976-d1a2950bc58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_CommitmentsAndContingenciesLineItems_019fb8a9-f933-7030-a697-fd42029d998b" xlink:href="tlx-20260630.xsd#tlx_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_CommitmentsAndContingenciesTable_019fb8a9-f933-7aa1-83ad-29e274cabef0" xlink:to="loc_tlx_CommitmentsAndContingenciesLineItems_019fb8a9-f933-7030-a697-fd42029d998b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_019fb8a9-f933-781e-9c97-97e0c6b14bf5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractualCapitalCommitments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_CommitmentsAndContingenciesLineItems_019fb8a9-f933-7030-a697-fd42029d998b" xlink:to="loc_ifrs-full_ContractualCapitalCommitments_019fb8a9-f933-781e-9c97-97e0c6b14bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tlx_ResearchAndDevelopmentsCommitmentsContractualObligations_019fb8a9-f933-7ec5-bdb4-693f4f39bb43" xlink:href="tlx-20260630.xsd#tlx_ResearchAndDevelopmentsCommitmentsContractualObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_CommitmentsAndContingenciesLineItems_019fb8a9-f933-7030-a697-fd42029d998b" xlink:to="loc_tlx_ResearchAndDevelopmentsCommitmentsContractualObligations_019fb8a9-f933-7ec5-bdb4-693f4f39bb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitments_019fb8a9-f933-75d5-870e-0b2077cf650e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tlx_CommitmentsAndContingenciesLineItems_019fb8a9-f933-7030-a697-fd42029d998b" xlink:to="loc_ifrs-full_CapitalCommitments_019fb8a9-f933-75d5-870e-0b2077cf650e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
